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Preface
This thesis was prepared at the Department of Bio - and Health informatics, at
the Technical University of Denmark (DTU) in fulfilment of the requirements
for acquiring a Ph.D. degree. It describes the use of genomics to characterize
phages in a commerical cocktail as well as sewage samples from different
locations around the world, and mathematical modeling to study the factors of
phage susceptiblity in Staphylococcus aureus. The thesis consists of a general
introduction, two research papers and one manuscript in prepartion produced
during the period 2014 - 2017.
The work was carried out under the supervision of professor Morten Nielsen
as well as the external supervisors Mette Voldby Larsen (CEO of GoSeqIt,
formerly associate professor at DTU Systms Biology) and Henrik Hasman
(special consultant at Statens Serum Institute, formerly senior researcher at
DTU Food). The Ph.D. was funded by DTU.
Lyngby, November 2017
Henrike Zschach
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Abstract
Bacteriophages, viruses that prey on bacteria, have been applied since the
1920’s to treat and prevent bacterial infection. After the discovery of antibi-
otics, this route was however largely abandoned. Now, with antimicrobial
resistance in human-pathogenic bacteria on the rise and a dire need for alter-
natives, phage therapy once again takes center stage.
Phage therapy holds the promise of substantial benefits both from the economic
as well as the public health perspective but also holds distinct challenges. The
aim of this PhD was to address how bioinformatics tools, specifically genomics
and mathematical modelling, can be applied to move the field towards a future
of actual phage therapy in humans. It is composed of three related research
projects.
The first part of this thesis is an introduction to various topics and methods
relevant to the research projects that jointedly make up this PhD. Chapters
1 - 3 deal with phages, their use in therapy and the nosocomial pathogen
Staphylococcus aureus. Following that, Chapter 4 and 5 provide an overview
of Next Generation Sequencing as well as commonly employed genomics tools,
while Chapter 6 details basics of Machine Learning.
The second part, divided into three chapters, presents the three research
projects. In project 1, an important commercial phage cocktail with a long
history was sequenced and its component phages analyzed. It was found that
the cocktail is composed of at least 23 different phage types, which were present
in differing abundances. Some of these phage types were successfully amplified
on a collection of in-house bacteria corresponding to the cocktail’s stated
bacterial targets. Further, no harmful genes were detected in the cocktail.
Project 2 deals with phage communities in sewage by comparing samples from
around the world to each other as well as to databases of available phage
genomes. It revealed a great diversity in the sequences, many of which were
distant from all known phages. The phage content of the different sample
locations exhibited a rather stable genomic distance that was not influenced
by whether the locations were geographically close or not.
Project 3 had the goal of identifying gene families in the extensive accessory
genome of the hospital pathogen Staphylococcus aureus that influence its sus-
ceptibility to clincal phage preparations. This was done by phage testing a set
of patient-derived S. aureus isolates against a panel of phage preparations. We
then sought to model the results using the bacteria’s genetic background as
features. Doing so, we built nine models with sufficient explanatory power over
the susceptibility outcome and from them identified a set of 167 gene families
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relevant for phage susceptibility.
The third part of the thesis consists of conclusive remarks and a critical re-
flection on how each of these projects has impacted the field and how they are
connected as well as pointing out directions for future investigations.
In summary, the work included in this this thesis focuses on applying genomics
and mathematical modelling to questions related to phage therapy.
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Dansk resumé
Bakteriofager, virus der inficerer bakterier, er blevet anvendt til forebyggelse
og behandling af bakterielle infektioner siden 1920’erne. Efter opdagelsen af
antibiotika blev denne praksis dog i det store og hele opgivet. Med den kraftige
stigning i antibiotikaresistens blandt humane sygdomsfremkaldende bakterier,
og det deraf fremkomne akutte behov for alternativer til antibiotika, træder
fag-terapi endnu engang frem på hovedscenen.
Fag-terapi bærer potentialet til store økonomiske såvel som sundhedsmæssige
fordele, men indeholder også specifikke udfordringer. Formålet med denne PhD
var at addressere hvordan bioinformatiske metoder, i særdeleshed genomics og
matematisk modellering, kan anvendes til styrkelse af det videnskabelige felt
med henblik på en fremtid hvor fag-terapi i mennesker er en realitet. PhD’en
er opbygget af tre relaterede forskningsprojekter.
Første del af afhandlingen udgøres af en introduktion til diverse emner og
metoder med relevans for de forskningsprojekter, der tilsammen udgør PhD’en.
Kapitel 1-3 omhandler fager, deres terapeutiske brug og den nosokomielle
patogen Staphylococcus aureus. Efterfølgende giver kapitel 4 og 5 et overblik
over Next Generation Sequencing samt metoder, der ofte bruges i genomics.
Kapitel 6 omhandler basale maskinlæringsprincipper.
Den anden del, opdelt i tre kapitler, præsenterer de tre forskningsprojekter.
I projekt 1 blev en vigtig kommerciel fag-cocktail med en lang historik se-
kventeret, og de enkelte fager, der udgør cocktailen, blev analyseret. Det blev
fundet at cocktailen bestod af mindst 23 forskellige fag-typer, som var tilstede
i forskellig mængde. Nogle af disse fager blev med succes opformeret v.h.a.
en lokal samling af bakterier, der repræsenterede de typer bakterier, som co-
cktailen var rettet imod. Der blev ikke fundet nogen skadelige gener i cocktailen.
Projekt 2 omhandler fag-samfund i spildevand, hvor prøver fra verden over blev
sammenlignet med hinanden og med fag-genomer i databaser. Dette viste en
høj diversitet i sekvenserne, hvoraf mange kun lignede de kendte fager meget
fjernt. Fag-indholdet i prøverne udgjorde en forholdsvis stabil genomisk for-
skellighed, der ikke blev påvirket af den geografiske tæthed hvormed prøverne
var blevet taget.
Projekt 3 havde til formål at identificere gen-familier i den del af genomet af
Staphylococcus aureus, der varierer indenfor arten, og som påvirker bakteri-
ens følsomhed overfor kliniske fag-blandinger. Dette blev gjort ved at teste
et sæt af S. aureus isoleret fra patienter mod et panel af fag-blandinger. Vi
forsøgte dernæst at modellere resultaterne i forhold til bakteriernes genetiske
baggrund. I denne proces byggede vi ni modeller, der i tilstrækkelig grad kunne
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forklare den observerede følsomhed, og fra disse modeller identificerede vi 167
gen-familier med relevans for bakteriernes følsomhed overfor fager.
Den tredje del af denne afhandling udgøres af de afsluttende konklusioner samt
en kritisk refleksion over hvilken indflydelse hver af disse projekter har haft
på det videnskabelige felt og hvordan de er forbundne. Derudover udpeges
retningslinjer for fremtidige undersøgelser.
Summa summarum, det arbejde, der er inkluderet i denne afhandling, fokuserer
på anvendelsen af genomics og matematisk modellering til spørgsmål relateret
til fag-terapi.
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3 CHAPTER 1. PHAGES
1 Phages
1.1 Phage biology
Bacteriophages, shortly referred to as phages, are viruses that infect bacteria.
They are the most abundant biological entity on the planet, with 1031 phage
particles estimated in the biosphere [1]. A cartoon of a T4-phage is shown in
Figure 1.1.
The two principal lifestyles observed in phages are the lytic and the lysogenic
cycle. Both begin with phage adsorption to a suitable host cell and injection
of the phage DNA. In the lytic cycle, the host metabolism is taken over by the
invading phage DNA and tuned to replicate said DNA as well as transcribe
it to the proteins necessary to produce new phage particles. Once the new
phages are assembled, the host is lysed. In short, during the lytic cycle, phage
progeny is produced and released.
Figure 1.1. Cartoon representation of a T4-phage. It is struc-
turally composed of a capsule or head, a tail shaft and tail fibers.
During the lysogenic cycle however, the phage DNA remains inside the bac-
terial cell, usually as an integrated prophage or more rarely as a plasmid. It
then replicates together with the host cell, effectively creating a new copy of
the phage every time the host divides. In this state, the bacterial host may be
referred to as a lysogen. An intact prophage may switch back to the lytic cycle
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and initiate production of phage progeny and host lysis as described above.
It is thought that this switch occurs as a response to stress on the host cell,
which can indicate that prospects of survival and further division of the host
are unlikely [2].
1.2 Phage taxonomy and genomics
The official authority of phage taxonomy is the International Committee on
Taxonomy of Viruses (ICTV). In the broadest context, phages are classified
based on their morphology and type of genetic material. Both single-stranded
and double-stranded RNA and DNA genomes have been observed, as well as a
range of different morphologies, but by far the most common (90%) are tailed
phages with double-stranded DNA genomes [3]. Those phages belong to the
order of the Caudovirales, which can further be subdivided into three families:
Myoviridae, Siphoviridae and Podoviridae.
Figure 1.2. Morphology of the three families within the Caudovi-
rales. A: Myoviridae. B: Siphoviridae. C: Podoviridae. Adapted
from [4].
All Caudovirales are tailed phages composed of a capsid or head with cubical
symmetry that contains the DNA and a helical tail shaft [3]. Additionally,
they often have structures at the end of the tail to facilitate host-recognition
and docking, such as base plates, spikes or tail fibers.The three families have
distinct tail morphologies and are identified by electron microscopy. Myoviri-
dae are marked by long, contractile tails, Siphoviridae by long, non-contractile
tails and Podoviridae by short tails. Examples for each family can be seen
in Figure 1.2. This division highlights the major problem of the current clas-
sification system: It requires isolation and visualization of the virion. It is
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therefore not possible to officially classify phages known only from metagnomic
sequencing or prophages identified in bacterial genomes.
As of now, genome-based taxonomy remains difficult because there are no
genes shared among all phages that could serve as a marker such as 16s for
all cellular life forms [1]. While it is true that bacterial species identification,
especially in the epidemiology context, has moved towards sampling a larger
proportion of the genome, the sampling of rRNA genes has evolutionized the
phylogeny of cellular life by enabling researches to draw a tree of life and
place every know lifeform in it. The same is not possible for phages, though
efforts have been made to build trees based on overall genome similarity as for
example the Phage Proteomic tree by Rohwer and Edwards [1].
Those efforts are hindered by the fact that phage sequences are extremely
diverse. This is especially true for phages with non-overlapping host ranges, to
the extent where two phages of different hosts seldom share extensive stretches
of nucleotides unless they are closely related [5]. In concert with their bacterial
hosts, phages have been described to constitute the greatest genetic diversity
on earth [6]. The evolution of both phage and bacterial genomes are hugely
driven by their interaction with each other, locked in an evolutionary battle of
defense-counter-defense mechanism [7].
Phage genomes also range widely in size from 2.4 kb in Leuconostoc phage L5
[5] to  500 kb in Bacillus phage G [6]. Further, their genomes are extensively
mosaic, which may be a consequence of frequent horizontal gene transfer [7].
Nonetheless, genes for related functions tend to cluster together into segments
[3]. Different segments may have a distinct evolutionary history [7].
In October 2017, 6377 phage genomes were available in NCBI’s genbank and
2943 in the phantome database, a dedicated phage resource. There is some
overlap across databases. After homology reduction on 100% sequence identity,
there are 5570 unique phage genomes known.
In accordance with the enormous diversity described above, the majority of
open reading frames found on new phage genomes typically code for proteins
with no known function or homolog [8].
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2 Phage therapy
The application of phage to treat bacterial infection, commonly referred to as
phage therapy, is a promising alternative to antibiotic treatments which are
proving increasingly difficult with the spread of antibiotic resistance. Phages
can either be used as purified single phage preparations or as cocktails com-
posed of many different phages. Both procedures are in use today [9].
2.1 Bacterial phage resistance mechanisms
As with antibiotics, bacteria may develop resistance towards phage infection.
There are several strategies: Evasion of phage recognition, recognition and
degradation of phage DNA, general interference with the phage reproductive
cycle, and altruistic abortive infection where host cells go into cell death before
the phage has finished producing progeny [10].
The first step of phage infection is recognition of and irreversible binding of the
phage particle to the host cell. Seeking to evade this recognition by modifying
the phage binding site or masking the receptor is an obvious strategy and there
are many examples of this in the literature as well as examples of counter-
mutation by the phage tail fiber to recognize the altered receptor [11–14].
After successful injection of the phage DNA, the infection can still be stopped
by degrading the phage DNA before it takes over the host metabolism. The two
most widely-known systems for that are restriction-modification and CRISPR-
Cas. Restriction-modification is a 2-component system in which a methylase
introduces a specific methylation pattern to the host DNA. DNA that lacks this
methylation pattern, i.e. invading foreign DNA, is cut by the accompanying
restriction enzyme [10]. Though being a wide-spread phenomenon in bacteria,
CRISPR systems are curiously absent in the opportunistic hospital pathogen
Staphylococcus aureus [15] which is the focal pathogen in this thesis. They will
therefore not be described in detail.
Finally, the successful production of phage progeny can be thwarted by the
host cell by interfering with one or several steps in the phage replication
process. Those systems are referred to as abortive infection systems and, un-
like the defense systems described above, result in the death of the host cell [10].
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There have also been examples of quorum sensing regulating receptor expres-
sion in E. coli and thereby reducing the number of phage infections when it
is growing in dense populations [16]. In addition to these bacteria-encoded
defense mechanism, acquiring a prophage may protect the bacterial host via
the superinfection exclusion system [10].
Despite the plethora of defense mechanisms present, phage therapy can still
succeed since, in contrast to antibiotics, phages constantly evolve in concert
with their host. Furthermore, there is evidence that the use of cocktails con-
taining complementary phages may reduce the emergence of resistance [17, 18].
2.2 Beginnings
The beginnings of phage therapy go back all the way to the discovery of phages
in the late 1910’s. In 1915, the Englishman Frederick Twort discovered an
agent with bacteriocidal potential on a culture of Staphylococcus. The agent
was transferable between cultures and could not be inactivated by Chamber-
land filtration, meaning it must be extremely small. He published his findings
in the Lancet but was unable to follow up on them due to the disruption by
First World War. Two years later, in 1917 the Frenchman Felix d’Herelle made
similar observations. He went on to perform animal studies as well as human
trials to test the potency of this agent, which he dubbed ‘bacteriophage’ in
preventing and mitigating bacterial infection. From there on, therapeutic use
of phages quickly expanded during the 1920’s [19].
However, controversy about the nature of phages remained and many phage-
derived treatments were carried out in poor understanding. Detailed reasons
for this are listed by Harper et al in a review paper titled ‘Phage therapy:
Delivering on the promise’ [19]. Overall, the supporting evidence for phage
treatment was found unconvincing. Phage therapy was therefore deemed
inferior to newly discovered antibiotics and was eventually abandoned in the
Western world around the 1940’s.
2.3 Phage therapy today
Today, phage therapy is almost exclusively available in Russia and Georgia.
There are exceptions under the experimental treatment umbrella, see below. In
both Russia and Georgia, phage preparations may be purchased as ready-for-
use products in pharmacies. The main producers are the companies Microgen
(Russia) and Eliava Bio Preparations (Georgia). In this thesis, the focus will
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be on Georgian phages.
Eliava Bio Preparation is affiliated with the Eliava Institute, whose roots
go back to the very beginning of phage therapy. In 1923, d’Herelle was
convinced by his colleague George Eliava to co-found an institute for bac-
teriophage research in Eliava’s native country, Georgia. A photograph of
d’Herelle and Eliava working together, presumably taken in Georgia, is shown
in Figure 2.1.Though Eliava was later executed and turbulent times followed
during the break-up of the Soviet Union, the institute still exists today. It
is now known as the George Eliava Institute of Bacteriophages, Microbiology
and Virology (Eliava Institute for short) and has accumulated an immense
amount of knowledge. The Eliava Institute offers 6 different phage prepara-
tions, among them the INTESTI cocktail which has been analyzed in this thesis.
Figure 2.1. Photograph of Felix d’Herelle (mid) and George
Eliava (right), ca. 1930’s. Taken from the Eliava In-
stitute’s website at http://eliavaphagetherapy.com/about-eliava-
institute/george-eliava-about-eliava-institute/.
In addition to that, phage therapy is offered to specific cases in the phage
therapy unit of the Hirszfeld Institute in Wroclaw, Poland. This use-case
is possible as an experimental therapy under the umbrella of the Helsinki
declaration, available as a last resort treatment for patients suffering from
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chronic, treatment-resistant bacterial infections [20].
Figure 2.2. Multiple phages of species ’ISP’ attached to their
host Staphylococcus aureus. Bar: 500nm. Reprint from [21].
There are several challenges connected with the use of phage therapy in the
Western world. They are both of legislative and regulative as well as practical
nature [22]. In the dogma of evidence based medicine a therapeutic should
be both effective and safe as well as have a well-characterized mode of action.
Phages are generally regarded as a viable solution to the antibiotic crisis by
legislation authorities1. Their ubiquitous presence in nature and their inherent
inability to interact with eukaryotic cells suggests that they should be safe
to use in human therapy. However, it holds true that phages carry bacterial
virulence factors and in many human-pathogenic bacterial species phages and
phage associated mobile genetic elements have been identified as essential to
their pathogenicity. It is therefore necessary to thoroughly characterize a
candidate therapeutic phage on a genetic level.
1As evidenced both by the fact that FDA does give approvals for phages as emergency
INDs and by their stated commitment to ”facilitating the testing of phage therapy in clinical
trials” [23]
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Further, for phage therapy to be effective it is necessary to either identify
the infecting bacteria down to strain level and test it against a library of
phages, or to use a single very broad phage or phage cocktail. In case of the
broadband approach the advantage of phages as highly specific agents over
antibiotics may be lost. On the practical side, there are questions regarding
the mode of delivery since phages are much larger than chemical drugs and it
is not clear which sites of the body can be reached effectively by simple oral
administration. Another practical consideration is whether phages can induce
immune reactions when given in the blood stream as some suggest as mode of
delivery.
The way to legislate phage therapy is to go through the legislative channels
commonly applied to all medical drugs. However, the very nature of phages
as viruses makes them not very suitable for approval criteria that have been
designed for chemical drugs, which will not change their composition over time
nor be amplified when in contact with their target. Nevertheless, the interest
in finding a feasible way to fit phages into the drug legislation is considerable
and those challenges will eventually be overcome. There are several initiatives
currently underway that aim to provide sufficient evidence regarding efficacy
and non-toxicity of phage therapy. Most outstanding is Phagoburn, a phase
I-II clinical trial in which a phage preparation is used to treat burn wounds
infected with Pseudomonas aeruginosa. It was initiated by the French company
Pherecydes Pharma and is being carried out in collaboration with 3 partners
and 11 clinical sites (see http://www.phagoburn.eu/). This is a landmark
clinical trial that hopefully will aid to pave the way for phage therapy in
Europe and the USA.
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3 Staphylococcus aureus
Staphylococcus is a genus of gram-positive spherical bacteria that grow in
grape-like clusters. There are several species, but in humans mainly S. aureus
and S. epidermidis are clinically relevant [24]. Both species have been found
in the normal bacterial flora of healthy individuals with about 20 - 30% of the
human population colonized asymptomatically by S. aureus [25]. S. aureus
is known to colonize the nasal passage, skin and mucosal surfaces while S.
epidermidis is a prevalent colonizer of the skin [26].
In addition to asymptotic colonization S. aureus is also known as an oppor-
tunistic pathogen that frequently causes wound and skin infections as well
as life threatening conditions like pneumonia, sepsis and endocarditis [26–28].
According to Deurenberg et al the majority of nosocomial infections today are
caused by S. aureus [29].
Such infections are especially problematic when caused by methicillin-resistant
S. aureus (MRSA). In recent years, the spread of MRSA has increased greatly
in hospital environments, which is a substantial threat to immunocompromised
patients. In addition to hospital-acquired MRSA (HA-MRSA) there are also
incidents of community acquired MRSA (CA-MRSA), which signifies MRSA
strains that originate from non-hospital environments. CA-MRSA can still
spread in hospitals once introduced. CA-MRSA often has additional virulence
factors compared to HA-MRSA, e.g. Panton-Valentine-Leukocidin (PVL) [29].
CA-MRSA is regarded as a particular health-threat because of its ability to
infect young healthy people who lack the known risk factors for MRSA, as
opposed to HA-MRSA which is prevalently a problem in immunocompromised
individuals [26, 30].
Genetically, S. aureus has been described as a highly clonal species whose
core genome is very conserved. Mobile genetic elements, most of which are of
phage origin, are what mainly accounts for the diversity of S. aureus strains
and not least many of the bacterium’s virulence factors [15]. That means that
the evolution in S. aureus seems to be largely phage-driven. Deghorain et al
report that the ’accessory genome’ may constitute as much as up to 25% of a
S. aureus genome, making the species highly adaptable [28]. Only two years
after the introduction of penicillin, a resistant S. aureus strain was detected
in 1942 and the same repeated two years after the introduction of methicillin
[29], which drastically underlines the speed with which S. aureus adapts.
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Furthermore, it seems that pathogenic S. aureus strains favor the mobilization
and atypical genomic integration of phages compared to strains that are purely
colonizing. This again emphasizes the role of phage derived mobile genetic
elements for the pathogenesis of S. aureus [28].
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4 Sequencing Technologies
4.1 Second generation sequencing
Second generation sequencing, also referred to as next generation sequencing
or massive parallel sequencing, is currently the most commonly used tech-
nology to produce sequencing data. The target DNA is hereby sheared into
fragments which are then clonally amplified and millions of them sequenced
in parallel, hence the name massive parallel sequencing [31]. A scheme of
the workflow is depicted in Figure 4.1. DNA targets can differ from small
PCR fragments (amplicons) to retro-transcribed cDNA in the case of RNA
sequencing to de novo sequencing of full genomes [31]. In the context of this
thesis I will mostly speak of whole genome sequencing (WGS) which aims
to uncover the full sequence of a target genome. There are three principal
providers of second generation sequencing: Illumina, 454 pyro sequencing and
Ion Torrent, of which Illumina remains the most widely used. Support for 454
sequencing was stopped in 2015 [32]. Each of them outputs a large amount
of short sequenced DNA fragments, called reads, that can later be combined
into longer contiguous fragments known as contigs by a process called de novo
assembly or mapped to a reference genome [33].
The advantages of second generation sequencing are that it is very affordable
and produces a large amount of data. The main drawback is that the read
length is very short, on the order of 35 to 700 base pairs [34]. This is caused
both by limitations in the sequencing technology and by the fact that DNA
has to be fragmented for the amplification step. The re-assembly of reads
into genomes afterwards is a non-trivial problem. Though various assembly
approaches exist, none of them are perfect and it is often not possible to
recover a single, closed genome from the data without performing additional
PCR over the contig edges or mapping the reads to a closed reference genome.
4.2 Third generation sequencing
In recent years, a new generation of sequencing technologies, commonly re-
ferred to as third generation sequencing or single molecule sequencing, has been
developed. The major difference to second generation is that instead of gener-
ating enormous libraries of short fragments of DNA, samples are sequenced as
single molecules without being fragmented. There are two distinct approaches:
Nanopore sequencing, as employed by Oxford Nanopore, and single-molecule
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Figure 4.1. Scheme of the Illumina sequencing workflow. The tar-
get DNA is first sheared into a fragments and ligated with adapters
during a process called library preparation. Afterwards, the DNA
fragments are immobilized on the surface of the flow cell and ampli-
fied. One of the strands is then removed to prepare for sequencing
by synthesis. Specialized nucleotides labeled with fluorescent dye
are added. Upon binding, they release a fluorescence signal corre-
sponding to the base that was just added. Reprinted from [35].
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real-time sequencing (SMRT), offered by PacBio.
By retaining the target DNA in large fragments during sequencing, possibly
encompassing the full genome, the problem of assembly is significantly reduced
[36]. Another aspect is a greater ease in sample preparation compared to sec-
ond generation sequencing, enabling these technologies to be applied outside
of laboratory settings [32]. This is especially true for the Oxford Nanopore.
Until recently, those technologies were however plagued by high error rates of
up to 20% for PacBio [37]. For phages with their very mosaic genomes long
read sequencing would be advantageous if the high error rate can be reduced
or corrected with short reads from second generation sequencing. For now,
this approach remains very expensive.
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5 Genomics
5.1 Genomics Tools
The advance of affordable and fast WGS has enabled the development of many
sequence based analysis methods.
The first step in the analysis of sequencing data is quality control and trimming
of the raw reads. This is necessary because sequencing is not error-free and low
quality reads may negatively affect the analysis by introducing noise. There
are many different trimming tools available. In my work I have used fastQC
[38] for read quality control and PRINSEQ [39] for trimming. Depending on
the desired analysis, read data can then be assembled into contigs. Different
approaches for assembly exist but the most successful assemblers to date are
based on de Bruijn graphs. A de Brujin graph is a graph representation of a
sequence (or several sequences) where each k-mer is a node and each edge is
an overlap between k-mers. A k-mer is a short sequence fragment of length
k. Assembly is then performed by resolving the de Bruijn graph. Examples
for de Bruijn graph assemblers are velvet [40] and SPAdes [41], both of which
have been used in this thesis.
Other than assembling reads one can also map them to a reference genome or
to already assembled contigs. Mapping could in principle be performed with
any alignment algorithm but because of the large number of reads, typically
in the millions or billions, there are specialized tools for this purpose. The
tool used for mapping in this thesis was the Burrows-Wheeler aligner(bwa) [42].
A substantial part of genomics is based on sequence comparison, which can be
done either by alignment or based on matching k-mers. The oldest and most
widely known alignment algorithm is the basic local alignment search tool
(BLAST) [43], which now exists in many variations and has played a pivotal
role in the development of the genomics field. BLAST is most commonly used
for database searches, such as in the ResFinder [44] and VirulenceFinder [45]
tools which employ BLAST to scan a query sequence for known antimicrobial
resistance and virulence genes respectively. Another application of BLAST
is to estimate distance between sequences via the average nucleotide identity
(ANI). ANI is for example be used for species delineation.
Other sequence comparison methods are based on counts of shared k-mers.
Two such tools used in this thesis are KmerFinder [46], an algorithm that com-
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putes sequence similarity in k-mer space, and cd-hit [47], a sequence clustering
algorithm used for homology reduction in datasets.
More specialized tasks often combine sequence similarity search and sequence
features such as GC content, tetranucleotide frequencies, genomic signatures
such as ribosome binding sites, secondary structure elements ect. Examples
used in this thesis are gene calling and functional annotation using prodigal
[ref], GeneMarkS [48] and RAST [49].
5.2 Metagenomics
Metagenomics is the sequencing and subsequent analysis of mixed DNA sam-
ples, i.e. samples that contain DNA from many different microorganisms
without separating those organisms before. Those samples are usually envi-
ronmental [33].
The shift from single organism genomics to metagenomics is hugely motivated
by the desire to understand the communities in which microorganisms live and
function as opposed to studying them as isolated entities which is not their
natural state [50]. Further, the majority of bacteria are not easily cultivated.
The same applies to phages, who naturally exist in close interaction with their
bacterial hosts as well as with each other via competition as well as exchange
of genetic material during co-infection. As such, the metagenomics approach
is well suited to study phage communities in the natural environments. The
majority of genomics tools described in the section above are also applicable
to metagenomics datasets.
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6 Machine learning
Machine learning can broadly be divided into supervised and unsupervised
learning tasks. In a supervised learning task both input and output are known
and the desired outcome is to find a function that describes their relationship.
In contrast to that, when data without known outcomes is available you have
an unsupervised learning task. The goal is then to infer underlying principles
in the data. In this thesis, only supervised learning was used.
6.1 Generalized linear models
There are many different algorithms that can be used for mapping the input
onto the output, however, in this thesis I will focus on generalized linear
models. The generalized linear model (GLM) concept unifies several often
used statistical models such as linear regression, logistic regression and multi-
nomial regression. In a GLM, model and output are related via a so-called
link function. This link function can be understood as determining the type of
regression [51].
In this thesis, a logistic GLM was used to model the phage susceptibility of
a set of bacterial strains as a function of their present gene families. Logistic
regression is the appropriate model type to use for categorical outcome variables
and the link function to use is then the logit function. Specifically, the model
structure was:
y s
NX
i=1
wi  xi with x 2 f0; 1g
where xi was 1 if the gene family i was present and 0 if it was absent, wi
was the weight assigned to gene family i and y was the predicted susceptibility
with 1 being susceptible and 0 being resistant. For details see the publication
included in Chapter 9.
6.2 Model training and performance evaluation
Generally in supervised learning tasks, models are trained on training data and
then evaluated on testing data. During training the goal is to minimize an error
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function between the prediction and the known true result. An often used error
function is the mean square error (MSE):
MSE =
1
N

NX
i=1
(Oi   ti)2
where N is the number of observations, Oi is the ith predicted value and ti
is the ith true outcome.
However, because of noise inherent in real-world data a maximally low training
error does not necessarily correspond to a good model since the model may
then start matching the noise instead of an underlying trend. This phenomenon
is known as overfitting and is particularly a problem when the feature space
is large compared to the number of observations, as typically occurs in high-
dimensional models. Overfitting is problematic because the resulting model
will be a suboptimal description of the underlying process and hence generalize
poorly to the independent evaluation data. Moreover, it will lead to a vast
overestimation of the model’s performance.
The way to accurately measure model performance is to perform training and
testing inside a cross validation (CV) framework [52]. In this framework, the
data is firstly divided into partitions, then all but one of the partitions are
used to train a model and the last one is used to evaluate it. Each division of
partitions into training and test set is called a fold. This process is repeated
until each partition in turn has been the testing set. The point of cross
validation is to test the model’s performance on new, unseen data (i.e. the test
set) and thereby get a better estimate of the model’s ability to generalize. For
this thesis, training and testing of the logistic regression model was performed
inside a five-fold cross validation setup.
Another problem present in this dataset, but also in machine learning in gen-
eral, is data-redundancy. When data points are shared between training and
testing set, the classification problem becomes very easy and the model will
not learn to generalize to new data. In addition to that the model performance
will be overestimated. It is therefore important that data points assigned to
different cross validation partitions should not be similar.
There exist different measures of model performance. For a classification task,
the receiver operating characteristic (ROC) curve is a good choice as is illus-
trates the relationship between sensitivity and specificity. The sensitivity, also
known as true positive rate, is plotted on the y-axis and 1 - specificity, also
known as the false positive rate, is plotted on the x-axis shows. When perform-
ing a classification task, the model output is not a binary but a continuous
variable. This prediction score is then discretized into a class prediction based
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Figure 6.1. Scheme illustrating three different hypothetical ROC
curves. A: Perfect performance. In a model with this AUC, it
would be possible to place the classification threshold so that all
true positives are reported but none of the false positives. B: Re-
alistic performance. A model with this AUC will report more true
positives than false positives. C: Random performance. A model
with this AUC would report true positives and false positives in
equal amounts. Reprinted from [53].
on a classification threshold. Conceptually, a ROC curves displays for every
possible classification threshold the ratio of true positives to false positives. To
quantify the goodness of a ROC curve one calculates the area under the curve
(AUC). A perfect performance would yield an AUC of 1, a random performance
an AUC of 0.5. The AUC was used as the measure of performance in the the
third study of this thesis, see Chapter 9. An example of three theoretical ROC
curves and their corresponding AUCs can be seen in Figure 6.1. One can also
calculate separate AUC values for each cross validation fold. If the model is
robust, the performance values should be similar across all folds.
6.3 Ridge regression
The model used in the third publication of this thesis was further fitted via
Ridge regression during training. Ridge regression is a type of parameter reg-
ularization applied during training where the error is penalized with the sum
24 CHAPTER 6. MACHINE LEARNING
of squared coefficient weights, also called the L2 norm [51]. The error function
then becomes:
E =
1
N

NX
i=1
(Oi   ti)2 +  
MX
l=1
wl
2
where N is the number of observations and M is the number of features.
Further, Oi is the ith predicted value, ti is the ith true outcome, wl is the
weight of the lth feature and  is the strength of penalty.
A ridge regression shrinks the weights of features that have a low importance
while maintaining the values of weights that do have general importance [54].
In that way it reduces overfitting.  is typically tuned to achieve an optimal
regularization, as was also done in this thesis. This should be done inside a
nested cross validation as depicted in Figure 6.2.
Figure 6.2. Scheme of nested cross validation for finding the
optimal strength of penalty . Briefly, for each fold in the outer
cross validation and for each  in a range of values, an inner cross
validation is performed. In this way, one optimal  is identified for
each outer cross validation fold.
For each outer cross validation fold, an inner cross validation is performed.
Note that the inner cross validation only has access to the data in the training
set of the corresponding outer cross validation fold. In the inner cross vali-
dation, again all but one partition are combined into the inner training set
and the remaining partition is used for testing. In order to find the optimal
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strength of penalty , training and testing are performed for a range of 
values for each inner cross validation fold. In this thesis we chose 1e 10 to 1e5.
Afterwards, predictions are pooled across all inner cross validation folds (but
still separated by  values). and one mean square error per  is calculated.
This error can be plotted against  to visualize ’s influence on the model test
performance. An example is shown in Figure 6.3. The optimal lambda for
the current outer cross validation fold is the one that results in the minimum
MSE. This optimal lambda is used to train an additional model using the en-
tire training set of the outer fold and evaluating on the test set of the outer fold.
Figure 6.3. Plots of mean square error versus different strengths
of penalty . A low penalty values the error is comparatively high
since there is little regularization. With increasing  the error gen-
erally reduces until it reaches a minimum. Afterwards, the error
rises again as strength of penalty becomes too high. It can be
seen that the curves for the five different partitions follow a similar
trend and their minima coincide to a reasonable degree. This in-
dicates the model is robust. Taken from the supplement of paper
’Host-genomic determinants of phage susceptibility in MRSA’, see
Chapter 9.
This process is repeated five times for the five outer cross validation folds. A
robust model should have comparable optimal lambda values.
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6.4 Feature selection
For the dataset used in this thesis the number of features, i.e. gene families,
was much greater than the number of observations, i.e. strains. This makes
it difficult to find the proper weights and also we can assume that not all
features are equally important for the outcome [55]. It is therefore essential to
perform feature selection. Feature selection is a process that seeks to limit a
model’s feature space to only the most important features. This can be done
in several ways. To avoid overfitting it is however vital to perform feature
selection inside the cross validation framework. Otherwise, information from
the test set can influence which features are picked and the test performance
will therefore not be an unbiased estimation of performance anymore. For this
reason, only information from the training set can used to select features.
In this thesis, feature selection was performed by a pre-selection step followed
by a two-step model. During the pre-selection, gene families were filtered based
on their p-values resulting from an association analysis between occurrence of
the gene family and susceptibility outcome. Since this is done inside the outer
cross validation, only data from the respective training set was used in the
respective association analysis. Gene families passing the p-value threshold
were admitted to an initial regression model. This model was then trained
on the same training data used to select the gene families and tested on the
left-out test set. Each gene family was assigned a regression weight wi during
training. After that, we moved on to the next outer CV fold and so on five
times. In this way, five weights were obtained for each gene family. If a gene
family was not picked by pre-selection in one of the folds, its weight in this
fold was ’not applicable’ (NA). Lastly, from this we selected gene families with
regression weights greater than a certain threshold in at least three of the five
partitions, to use as features in a final model.
Part II
Studies included in the thesis
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7 Sequencing of the INTESTI phage
cocktail
The field of phage therapy in general has gone through a great revival in
Western research during recent years, owed in large parts to the looming
antibiotic resistance crisis. This has understandably created an interest in
the phage cocktails already in use in Russia and Georgia. In both of these
countries phage therapy has a long history going back to the 1920’s/30’s and
especially the Eliava Institute in Georgia has been a major player in piloting
phage research and exporting phages across the Soviet Union [56].
In the following paper, we show what can be done with a metagenomics ap-
proach to characterize an existing phage cocktail. This project started as my
Master’s thesis back in 2014 and then continued on to become the first paper of
my PhD. It began with Karina Sreseli, a Georgian secretary in our department,
who shared the story of how she had been treated with phage cocktail as a
child. At that time my supervisor Mette Larsen was becoming very interested
in phages and it was our luck that Karina still had contacts to Georgia - specif-
ically to the Eliava Institute where phage cocktails have been produced since
the 1930’s. Mette obtained a sample of INTESTI, one of the most famous and
longest used phage cocktails of Eliava, and from there on a long journey started
during which we met many people all the way from Georgia to the Evergreen
State College in Washington, U.S. Some of them become co-authors, others
advised us and it ended in a publication that has generated a fair share of
interest in the field due to the historical significance of INTESTI phage cocktail.
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Abstract: Phage therapy, a practice widespread in Eastern Europe, has untapped potential in the
combat against antibiotic-resistant bacterial infections. However, technology transfer to Western
medicine is proving challenging. Bioinformatics analysis could help to facilitate this endeavor.
In the present study, the Intesti phage cocktail, a key commercial product of the Eliava Institute,
Georgia, has been tested on a selection of bacterial strains, sequenced as a metagenomic sample,
de novo assembled and analyzed by bioinformatics methods. Furthermore, eight bacterial host
strains were infected with the cocktail and the resulting lysates sequenced and compared to the
unamplified cocktail. The analysis identified 23 major phage clusters in different abundances in
the cocktail, among those clusters related to the ICTV genera T4likevirus, T5likevirus, T7likevirus,
Chilikevirus and Twortlikevirus, as well as a cluster that was quite distant to the database sequences
and a novel Proteus phage cluster. Examination of the depth of coverage showed the clusters to
have different abundances within the cocktail. The cocktail was found to be composed primarily of
Myoviridae (35%) and Siphoviridae (32%), with Podoviridae being a minority (15%). No undesirable
genes were found.
Keywords: phage therapy; Eliava Intestiphage; whole genome sequence analysis; metagenomics
1. Introduction
Antibiotic resistance in human pathogenic bacteria is a threat to public health that has grown
immensely in the last years. The World Health Organization (WHO) recognized the severity of the
problem in two reports made public in 2012 and 2014, stating that “A post-antibiotic era—in which
common infections and minor injuries can kill—far from being an apocalyptic fantasy, is instead a
very real possibility for the 21st Century” [1]. It is therefore all the more urgent to secure alternative
treatment strategies. Phage therapy is one of the alternatives to antibiotics that for a long time has
been underexplored in Western medicine. Bacteriophages, viruses of bacteria, have been employed
to combat bacterial infections in certain Eastern European countries since the mid-1920s [2,3]. With
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the number of phages on earth estimated at 1031 in total [4], they are the most abundant entity in the
biosphere and, as natural predators of bacteria, they hold largely untapped therapeutic potential [5].
During the Soviet era, antibiotics were not readily available in the USSR, which contributed to
the widespread use of phages for treatment of various sorts of bacterial infections [6]. In particular,
the George Eliava Institute in Tbilisi, Georgia, founded in 1923, has more than 90 years of experience
in employing phages for treatment of bacterial infections in humans, either as single preparations or
in mixtures, i.e., phage cocktails.
Phage therapy is largely regarded as safe and effective in those countries where it is still
practiced [7–10]. This is reinforced by the long-standing tradition of its use. The enormous
body of experience with clinical phage therapy, which has primarily been reported in non-English
languages [11], is now more and more being made available to the scientific community
thanks to the concerted efforts of Elizabeth Kutter, Jan Borysowski, Harald Brüssow, Ryszard
Mie˛dzybrodzki, Andrzej Górski, Beata Weber-Da˛browska, Mzia Kutateladze, Zemphira Alavidze,
Marina Goderdzishvili, Revaz Adamia and others [8,9].
Additionally, a number of more recent trials have been carried out in accordance to the strict
guidelines demanded by legislative bodies and published, notably two T4 oral application safety
trials [12,13], a trial of Pseudomonas aeruginosa phages for treatment of chronic otitis [14], a phase I
trial of phage therapy for venous leg ulcers [15] and a trial of Russian phage cocktail administration
in healthy individuals [16].
Despite the growing body of evidence on the safety and efficacy of phage therapy, the technology
proves hard to transfer despite considerable interest by Western researchers. One of the challenges
is a lack of definition and characterization of the phages used, as the exact composition of phages in
the cocktails produced in Eastern Europe is largely unknown [17]. Advances in metagenomics and
decreasing sequencing costs have made it possible to analyze mixed phage samples without the need
to separate the component phages. This is especially essential when the specific bacterial hostsstrains
are unknown and the phages can thus not be individually propagated for traditional analysis. This
metagenomic approach was first used for marine viral communities in 2002 [18]. One of the latest
milestones in this endeavor consists of a metagenomic study of a Russian phage cocktail as well as a
safety trial, performed by McCallin et al. in 2013 [16].
Here, we present a metagenomic analysis of the longest-used such commercial phage cocktail
in the world, still routinely employed for human therapy in the Republic of Georgia. Intesti
bacteriophage was created at the Pasteur Institute, Paris by Felix d’Herelle [19] as a multi-component
treatment and prophylaxis of intestinal infections. From early on, the preparation is a combination
of phage active against Shigella, Escherichia, Salmonella, Enterococcus, Staphylococcus, Streptococcus and
Pseudomonas. Its advantages lie in its activity against a wide variety of enteric bacteria, allowing it to
be used empirically during the first days of gastrointestinal illness, before the microbiological culture
results are in, along with its frequent ability to help restore balance to the gut microbiome even where
no explicit pathogen has been identified as the cause of the problem.
Intesti bacteriophage was first used clinically in Georgia in 1937 by S. Mikeladze [20].
Already in 1938, M.N. Luria used Intesti-bacteriophage to study 219 patients suffering from either
dysentery (84 children and 27 adults with Shigellashiga (now known as Shigella dysenteriae) or flexneri)
orhemolytic intestinal disease caused by an unidentified bacterium (54 children and 54 adults).Most
had previously been treated unsuccessfully in other ways, but other treatments were stopped
during administration of the phage therapy. Adults were given 10 mL and children 2.5–5 mL
orally with carbonated water once a day, before meals. Improvement was observed in 163 cases
within 1–3 days. The results of this study and a number of others have been summarized in great
detail by Chanishvili [21] in her extensive 2009 literature review of the early practical application of
bacteriophage research, previously largely available only in Georgian.
There is an unknown, quite large total number of phages in the Eliava Intestiphage cocktail,
which has continually been evolved to meet current needs since it was first developed by d’erelle at
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the Pasteur Institute. At least one proprietary mother phage stock has been maintained through
the years for the phages targeting each genus of bacteria, and each of these is grown separately
using a proprietary group of bacterial strains of that genus, which is updated regularly as needed
to be able to better target new problem strains that have arisen. Each component thus produced
for a new commercial batch is tested on each member of a separate continually-updated broad
proprietary group of strains and remade if it does not adequately meet the established high host
range for that genus. New phages are periodically added to improve the needed host range for this
broadly-applicable commercial cocktail, which has been shown to have such high efficacy in a variety
of situations, both as a probiotic and to treat a wide range of gut problems that are often intransigent
to more narrowly targeted phage treatments and/or to antibiotic treatment. This challenges most
current common regulatory practices in countries other than Georgia, where the carefully defined
method of testing and regulation of Intestiphage takes this into consideration, with close cooperation
between the Ministry of Health regulatory body and the production facilities. The procedure
described above for preparing therapeutic bacteriophage is similar to the procedure described in a
chapter on phage production by Felix d’Herelle. The original chapter has been translated into English
by Sarah Kuhl and Hubert Mazure [22].
The Eliava Pyophage cocktail, for purulent infections involving Streptococcus sp., Proteus sp.,
Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, is the one other cocktail that has
evolved in similar fashion over the years. It should be kept in mind that Intestiphage and Pyophage
are generic names; other companies in both Georgia and Russia have been making and marketing
their own versions for the last couple of decades which have been evolved from the same initial
cocktails brought to what is now the Eliava Institute by d’Herelle and are regulated and regularly
upgraded in similar fashion. These other versions can be expected to work better in some specific
situations, worse in others, depending on their precise composition of phages and of the proprietary
hosts that are used in their production and testing. It will be very interesting to also do metagenomic
analyses of those other versions and see how their current composition compares, in reflection of this
evolutionary process.
2. Materials and Methods
2.1. The Intesti Phage Cocktail
Commercial “Intesti bacteriophage”, which is used mainly to treat bacterial infections of the
intestine, urinary tract and oral cavity in humans, was kindly provided by Nikoloz Nikolaishvili,
director of Eliava Bio Preparations LLC at the George Elivia Institute, Tbilisi, Georgia. The current
Eliava Intestibacteriophage contains sterile phage lysates active against Shigella (flexneri, sonnei,
Newcastle), Salmonella (Paratyphi A, Paratyphi B, Typhumurium, Enteritidis, Cholerasuis,
Oranienburg), Escherichia coli, Proteus vulgaris and mirabilis, Stapylococcus aureus, Pseudomonas
aeruginosa and Enterococcus. Intestibacteriophage is used for treatment and prophylaxis of
the following bacterial intestinal infections caused by the above mentioned microorganisms:
dysentery, salmonellosis, dyspepsia, colitis, enterocolitis, and dysbacteriosis (bacterial overgrowth).
Intestibacteriophage treatment per os (via oral route) is used from the first day of disease and is
continued for 5–6 days. Intestibacteriophage can be used for prophylaxisin situations where there
are large groups of people (for example military or schools), during seasonal peaks in order to reduce
occurrence of intestinal infections. The phage preparation developed for therapeutic and prophylactic
uses by G. Eliava Institute of Bacteriophages, Microbiology and Virology was awarded in 1978 Gold
Medals at the Exhibitions of All-Union National Achievements in Science and Technology.
From the mode of preparation, it follows that the Intesti cocktail is a complex mixture of phages
in different abundances, many of which may be closely related. This poses certain challenges both
in the sequencing and assembly. Furthermore, different batches of the cocktail may not be identical.
Our sample was manufactured in July 2013 and has the batch number M2-501.
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2.2. Host-Amplified Samples
In addition to sequencing the complete cocktail as a metagenome, we also amplified the
component phages on eight different hosts and isolated DNA from the resulting lysates, which are
assumed to be enriched only in the phages capable of infecting the given host. Those samples are
therefore reduced in complexity in comparison to the cocktail. The host strains used are part of an
in-house Danish collection and listed in Table 1 (Results Section). For each host, 5 mL liquid LB were
inoculated with 50 µL from an overnight culture and grown with shaking incubation at 37 ˝C. After
3 h the day culture was divided into two 2.5 mL samples, of which one was infected with 300 µL
of the cocktail and incubated for another 4 h with shaking. When the infected sample had visibly
cleared compared to the non-infected sample, indicating that host lysis had occurred, the lysate was
filtered through 0.22 µm syringe filters and subsequently treated the same as the Intesti whole cocktail
sample (see Sample Preparation). It should be noted that the bacterial host strains used to produce
the cocktail in Georgia are proprietary and thus were not available to us in Denmark.
Table 1. List of the strains used to specifically amplify phages from the Intesti cocktail and the number
of reads obtained in their sequencing. All strains were tested for susceptibility to the cocktail prior
to selection.
Host Bacterial Strain Number of Reads
Escherichia coli ATCC 25922 358,914
Enterococcus faecalis ATCC 29212 134,966
Pseudomonasaeruginosa 0407431-2 184,790
Pseudomonasaeruginosa PAO1_seq 265,772
Proteus vulgaris CCUG 36761 (ATCC 13315) 64,852
Salmonella typhimurium ATCC 14028 133,980
Shigellaflexneri iran_1s 225,664
Shigellasonnei iran_2s 401,722
2.3. Sample Preparation
All phage samples intended for sequencing were treated with 10 µL (20 units) of 2000 units/mL
DNAse (New England BioLabs, Ipswich, MA, USA) per mL of phage lysate and 5 µL of 20mg/mL
RNase (Invitrogen, Carlsbad, CA, USA) per mL of phage lysate to remove possible bacterial DNA
leftovers. Subsequently, the samples were treated with 4µL of 20 mg/mL Proteinase K (Merck
Milipore, Hellerup, Denmark) per mL of phage lysate to open phage capsids, followed by standard
DNA extraction by spin column using the Phage DNA isolation kit by NorgenBiotek (Product #46700,
Thorold, ON, Canada).
2.4. Sequencing and Genome Assembly
For each sample a DNA library was prepared from 10 ng of sample DNA using the Nextera XT
Sequencing kit (Part #15031942, Illumina, San Diego, CA, USA) and sequencing was performed on the
Illumina MiSeq system (Illumina, San Diego, CA, USA). The platform’s maximum read length was
251 bp corresponding to 251 cycles. The quality of the raw sequencing data was analyzed with the
fastQC tool [23] and it was trimmed extensively using the PRINSEQ [24] tool (trimming parameters
may be found in the Supplementary Table S1). Following quality trimming, the data were assembled
into contigs using the genovo algorithm [25] for the whole cocktail and samples amplified on E. coli,
Enterococcus, P. aeruginosa PAO1_seq, Salmonella, Shigellaflexneri and Shigellasonnei and the velvet [26]
assembler for samples amplified on P. aeruginosa 0407431-2 and Proteus.
2.5. Construction of Phage Clusters
Phage clusters were constructed by grouping contigs by their profiles of BLAST [27] hits to
NCBI’s non-redundant nucleotide collection (October 2014). Those hit profiles were obtained by
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applying a quality cutoff on the query coverage of 20% and on the E-value of 1 ˆ 10´10 to the raw
BLAST results. Contigs were sorted by size and the largest was automatically assigned to the first
contig group. Succeeding contigs either joined an existing group or initiated a new one depending
on the distance score (see below) between the current contig’s hit profile and the group’s hit profile.
The process is illustrated in Figure 1. Because of the high complexity of the cocktail, we find it useful
to think of those drafts as representing clusters of related phages and they are henceforth referred to
as clusters.
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Figure 1.Schematic illustrating the contig grouping process. In a first step, a BLAST search against 
the non-redundant nucleotide collection is performed for all contigs. Afterwards, a hit profile is 
generated for each contig by applying a cutoff of 20% on the query coverage and 1 × 10−10 on the  
E-value to the raw BLAST results. During the second step contigs are sorted by size and the largest 
contig is automatically assigned to group 1. The third step consists of comparing the second-largest 
contig to all existing groups using the scoring system described in the text and either assigning the 
contig to the group with the lowest distance score or opening a new group if the lowest score is 
greater than 0.9. It is repeated until all contigs have been assigned (though some contigs may be the 
only member of their respective group). 
The distance score Sd between two profiles was defined as the average distance of each hit in 
both profiles such that: 
• If the hit is only present in one of the profiles, its distance is 1.0. 
• If the hit is present in both profiles, the hit’s distance is the absolute value of the difference 
between the query coverage values, as defined below: 
Figure 1. Schematic illustrating the contig grouping process. In a first step, a BLAST search against the
non-redundant nucleotide collection is performed for all contigs. Afterwards, a hit profile is generated
for each contig by applying a cutoff of 20% on the query coverage and 1 ˆ 10´10 on the E-value to
the raw BLAST results. During the second step contigs are sorted by size and the largest contig is
automatically assigned to group 1. The third step consists of comparing the s cond-lar est contig to
all existin groups using t e scoring system described in the text and either assigning the contig to
the group with the lowest distance score or opening a new group if the lowest score is greater than
0.9. It is repeated until all contigs have been assigned (though some contigs may be the only member
of their respective group).
The distance core Sd betwee two profiles wa defi ed as the average distance of each hit in
both profiles such that:
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‚ If the hit is only present in one of the profiles, its distance is 1.0.
‚ If the hit is present in both profiles, the hit’s distance is the absolute value of the difference
between the query coverage values, as defined below:
Sd ppro f ilel , pro f ilekq “
řn
i“1
#
abs
´
querycoveragehitiinpro f ilel ´ querycoveragehitiinpro f ilek
¯
1.0; i f nothiti P pro f ilel _ nothiti P pro f ilek
n
(1)
where n is the unique number of hits in profiles l and k.
A contig group’s hit profile is the weighted average of the hit profiles of its member contigs and
it was updated every time a contig joined the group. The query coverage, i.e., to which extent a contig
is covered by that particular hit was thereby used as a scaling property ranging between 0 and 1. The
more of a contig is represented by the hit, the bigger the influence of that hit on the difference score.
This was done to address the modular nature of phage genomes [28].Contigs that had database hits
which were not shared by any other contigs were compared to known phages with regard to length,
coverage of the contig by the reference and percent sequence identity, in order to establish whether
they could be representing full phage genomes. Contig groups smaller than 5 kb in total size were
excluded from further analysis. They represent less than 1% of the assembly size and mostly had hits
to bacterial DNA, though upon further investigation many of those hits turned out to be confirmed
or suspected prophage or mobile element regions.
We further employed BLAST to identify contig groups from different samples that are thought
to originate from the same phage cluster. Contigs from the sample amplified on a Proteus host
were compared to NCBI’s non-redundant nucleotide collection (October 2014) and after checking
for sufficiently high depth of coverage those without hits were considered as belonging to novel
Proteus phages.
2.6. Analysis of the Depth of Coverage
The average depth of coverage was calculated for each contig by mapping the reads that were
previously used for assembly back to the contig. Following that, the average depth of coverage for
each cluster was calculated from the depth of coverage of its member contigs. We herein incorporated
contig length as a scaling factor in the calculation and thereby obtained the weighted arithmetic mean
of the cluster’s depth of coverage and weighted standard deviation of the same as defined below.
Depth of coverage of contig i,
xi “ N ˆ Lwi (2)
weighted mean depth of coverage of cluster j
xj “
řn
i“1 wi ˆ xiřn
i“1 wi
(3)
and weighted standard deviation of the depth of coverage of cluster j
σj “
gffeřni“1 wi ˆ `xi ´ xj˘2řn
i“1 wi
(4)
as used in this study, where N = number of reads mapped to contig i, L = average read length,
xi = depth of coverage of contig i, weight wi = length of contig i and n = the number of contigs in
cluster j.
Mapping was performed using the Burrows-Wheeler Alignment tool (BWA) [29]. Prior to
mapping, reads were quality trimmed (specifics may be found in Supplementary Table S1), however,
duplicates were not removed as had been done for the assembly.
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2.7. Gene Prediction and Functional Annotation
Putative genes were predicted in both grouped and un-grouped contigs. Nineteen near
complete draft genomes were submitted to the annotation server RAST [30] for functional annotation.
Additionally, gene calling was performed on all contigs using the GeneMarkS algorithm [31],
followed by a BLAST search against NCBI’s non-redundant protein database to infer annotation from
existing homologs and achieve an overview of the functions present in the phage cocktail. Annotation
was hereby extracted from the top BLAST hit with the additional requirement that the match to
this top hit had an E-value smaller than or equal to 1 ˆ 10´10. The results of the two approaches
were then compared. Two genes were considered to be the same if their start and end coordinates
were less than 10% of the gene length apart and in frame of each other; that is, if the difference
between the coordinates for the two genes was a multiple of three. The obtained annotation was
subsequently text-mined for genes considered to be undesirable in phage therapy, such as bacterial
virulence factors and genes related to lysogeny [32], as well as for genes speculated to enhance the
phages’ efficacy. For this part, we chose to focus on methylase genes which have been discussed
as a method to evade restriction by the bacterial host [33]. Furthermore, the complete assembly
was scanned against a database of known genes for acquired antimicrobial resistance by using the
ResFinder tool [34] and against a database of known virulence genes in E. coli, Enterococcus and
Staphylococcusaureus using the VirulenceFinder tool [35]. No gene prediction and annotation was
performed in the host-amplified samples.
2.8. Host Range Estimation
Lastly, in order to verify the cocktail’s capability to cause lysis of the specified pathogens, five to
ten strains were selected for each pathogen and tested for susceptibility towards the phage cocktail
by streaking the bacteria onto an agar plate perpendicular to a streak of phage solution. The selection
was oriented towards maximum diversity, including strains from different geographical origins
and different host reservoirs. For the pathogens only listed at genus level, different species were
tested. The strains and test results can be found in Supplementary Table S2. If lysis occurred in the
intersection zone, the bacterial strain was registered as being susceptible to the cocktail. Ambiguous
results were repeated in triplicate.
3. Results
3.1. Sequencing Statistics
After quality trimming the sequencing of the full Intesti cocktail resulted in 440,392 reads with
an average read length of 174.9 bp. De novo assembly yielded 420 contigs ranging in size from 500 to
134,226 bp and a total assembly size of 2041 kb.
In the host-amplified samples, the sequencing depth varied between the different samples. This
is indicated by the differing number of reads, see Table 1. Some of the reasons for this could be a
variation in the input DNA concentration, as well as amplification bias during library preparation
and during the sequencing process.
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Table 2. Overview of selected characteristics of the phage clusters identified in the Intesti sample. If known, the family, subfamily and genus of the closest database
reference as specified by the ICTV are given. In some cases, the closest reference phage has not been incorporated into the phage taxonomy yet but other references
have. For those, both the closest reference and the closest reference within the taxonomy scheme are given. The genus “rv5-like virus” has been proposed by several
authors [36,37], but is not confirmed in the current (2014) ICTV release. Remark that Bacteriophage G1 is annotated as a Staphylococcus phage.
Phage Cluster ClusterSize in bp
Reference
Accession
Average Coverage
of Phage Cluster
Average Percent
Identity Reference Phage Description Line
Phage
Family Subfamily Genus
Size
RatioCluster/Reference
D1 142,025 KC012913.1 99.97 99.80 Staphylococcus phage Team1,complete genome Myoviridae 1.01
AY954969.1 97.98 99.74 Bacteriophage G1, complete genome * Spounavirinae Twortlikevirus 1.02
D2 76,960 JX415536.1 87.89 87.60 Escherichia phage KBNP135,complete genome Podoviridae 1.00
D3 87,828 KC862301.1 98.97 96.16 Pseudomonas phage PAK_P5,complete genome Myoviridae 1.00
D4 69,023 KF562340.1 87.20 94.02 Escherichia phage vB_EcoP_PhAPEC7,complete genome Podoviridae 0.96
D5 150,530 FR775895.2 92.41 98.16 Enterobacteria phage phi92,complete genome Myoviridae 1.01
D6 81,563 AB609718.1 35.55 77.46 Enterococcus phage phiEF24C-P2 ,complete genome Myoviridae 0.57
D7 58,193 KJ094032.2 77.23 88.35 Enterococcus phage VD13,complete genome Siphoviridae - Sap6likevirus 1.06
D8 50,277 HM035024.1 98.16 90.67 Shigella phage Shfl1, complete genome Siphoviridae - Tunalikevirus 0.99
D9 39,912 EU734172.1 88.25 93.45 Enterobacteria phageEcoDS1, complete genome Podoviridae 1.02
D10 145,982 KJ190158.1 93.95 93.00 Escherichia phage vB_EcoM_FFH2,complete genome Myoviridae 1.05
DQ832317.1 93.72 92.62 Escherichia coli bacteriophage rv5,complete sequence - “rv5-like virus” * 1.06
D11 61,791 JX094499.1 96.33 92.95 Enterobacteria phage Chi,complete genome Siphoviridae 1.04
KC139512.1 95.15 93.86 Salmonella phage FSL SP-088,complete genome - Chilikevirus 1.04
D12 60,451 KJ010489.1 54.57 87.35 Enterococcus phage IME-EFm1,complete genome Siphoviridae 1.42
D13 188,630 GU070616.1 88.67 94.90 Salmonella phage PVP-SE1,complete genome Myoviridae “rv5-like virus” * 1.29
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Table 2. Cont.
Phage Cluster ClusterSize in bp
Reference
Accession
Average Coverage
of Phage Cluster
Average Percent
Identity Reference Phage Description Line
Phage
Family Subfamily Genus
Size
RatioCluster/Reference
D14 133,015 JX128259.1 94.55 96.24 Escherichia phage ECML-134,complete genome Myoviridae 0.80
DQ904452.1 93.42 96.00 Bacteriophage RB32, complete genome Tevenvirinae T4likevirus 0.80
D15 43,967 GQ468526.1 87.06 91.27 Enterobacteria phage 285P,complete genome Podoviridae 1.12
FJ194439.1 87.13 90.61 Kluyvera phage Kvp1,complete sequence Autographivirinae T7likevirus 1.11
D16 46,882 KM233151.1 93.68 91.47 Enterobacteria phage EK99P-1,complete genome Siphoviridae 1.06
JX865427.2 91.64 91.03 Enterobacteria phage JL1,complete genome Hk578likevirus 1.08
D17 41,098 AY370674.1 88.68 94.28 Enterobacteria phage K1-5,complete genome Podoviridae Autographivirinae Sp6likevirus 0.93
D18 41,016 HE775250.1 94.95 91.57 Salmonella phage vB_SenS-Ent1complete genome Siphoviridae 0.97
JX202565.1 92.76 91.41 Salmonella phage wksl3,complete genome Jerseylikevirus 0.96
F1 13,855 HG518155.1 99.97 99.02 Pseudomonas phage TLcomplete genome Podoviridae 0.30
AM910650.1 91.92 97.11 Pseudomonas phage LUZ24,complete genome - Luz24likevirus 0.30
F2 11,476 EU877232.1 99.94 91.42 Enterobacteria phage WV8,complete sequence Myoviridae - Felixounalikevirus 0.13
F3 5706 HQ665011.1 83.42 86.09 Escherichia phage bV_EcoS_AKFV33,complete genome Siphoviridae 0.05
AY543070.1 82.09 87.59 Bacteriophage T5, complete genome - T5likevirus 0.05
F4 2624 EF437941.1 98.59 97.76 Enterobacteria phage Phi1,complete genome Myoviridae Tevenvirinae T4likevirus 0.02
Proteus phage 104,213 - - - - Siphoviridae -
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3.2. Recovered Phage Clusters
Within the cocktail, 22 phage clusters were recovered by grouping using BLAST hit profiles (see
Materials and Methods); plus one novel Proteus phage cluster was cluster identified by comparing
contigs without hits between the Intesti sample and the Proteus host-amplified sample. All clusters
are listed in Table 2. They are denoted by a capital D and numbered, except for four smaller clusters
under 30 kb in size, which are regarded as containing fragments of phages and therefore denoted by
capital F instead. The reason those four clusters are thought to be fragments is that they are small
compared the known phages they resemble most, while the other clusters are of similar or greater
size than their BLAST hit. It is acceptable for a cluster to be of greater size since the cluster size is
cumulative of all member contigs and there can be several variant phages. Overall, clusters ranged in
size from 13.4 to 212 kb and were composed of between one and 56 contigs. Seventy contigs, which
together make up 217 kb of sequence or 10.6% of the total assembly size, had no significant hits to
NCBI’s nr nucleotide database. They could therefore not be assigned to a cluster. A list of clusters
recovered in the host-amplified samples may be seen in Supplementary TableS3.
3.2.1. Similarity to Known Phages
The most significant BLAST hits used to form the phage clusters were used to examine which
known phages a cluster seems to be related to. In Table 2 the reference phage with the highest identity
is listed for each cluster, together with the family and, if given, subfamily and genus of that phage
according to the ICTV. In cases where there is no taxonomical data available for the closest match but
for another match, this reference phage is also listed (compare D14, D15, D16, D18, F1 and F3). Based
on the phage family of their closest references, we inferred the potential family association of the
clusters. A BLAST search of the predicted tail fiber, DNA polymerase and capsid genes of the Proteus
phage revealed them to be most similar to those of Siphoviridae. We therefore predict the Proteus phage
cluster to belong to the Siphoviridae and count the reads mapped to it into that family. While larger
than most studied Siphoviridae (which are around 50 kb), the 104 kb Proteus cluster is still smaller than
the genomes of the T5 genus of phages. The depth of coverage is quite even along the two contigs
in this cluster, so it seems unlikely that the length has been artificially increased through collapsing
multiple phages into the cluster.
The clusters could be divided into three groups based on their similarity to their reference
phages: Clusters with several highly similar references (query coverage and percent identity >90%),
cluster with medium similar references (query coverage and percent identity between 90% and 70%)
and clusters that were very distant from all publically available phage sequences. The clusters with
several highly similar references are D1, D3, D8, D10, D11, D14, D16, D18, F1, F2 and F4. Specifically
for D1 and D3, the resemblance to their closest database reference was very pronounced. We therefore
conclude that we have identified phages that appear to be of the same phage species as Staphylococcus
phage Team1 (KC012913.1) and Pseudomonas phage PAK_P5 (KC862301.1), respectively, in the Intesti
phage cocktail. The other eight clusters in these groups can also be viewed as fairly close relatives of
the clusters described by their reference phages. The second group of clusters, with a slightly lower
but still apparent similarity to their references, was D2, D4, D5, D7, D9, D13, D15, D17 and F3. These
clusters contain parts that differed from their references, either because they were acquired from other
phage species or because they are novel. In contrast, the references for the clusters D6 and D12 were
quite distant, as can be seen by the low query coverage. This means that large parts of those two
clusters are novel.
Regarding the inferred taxonomy of the clusters, we were able to assign 13 of the clusters to
a suspected genus. Of those, four were assigned to the Myoviridae genera Twortlikevirus, T4likevirus
(two clusters) and Felixounalikevirus. A further six clusters were assigned to the Siphoviridae genera
Sap6likevirus, Tunalikevirus, Chilikevirus, Hk578likevirus, Jerseylikevirus and T5likevirus. Finally, three
clusters were assigned to the Podoviridae genera T7likevirus, Sp6likevirus and Luz24likevirus. Two
more clusters had reference phages that have been proposed for the new Myoviridae genus rv5-like
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virus, however this genus remains unconfirmed in the 2014 ICTV release. Another six clusters have
reference phages, which have not been placed in the official taxonomy yet. Furthermore, the cluster
D6 and the Proteus phage cluster may represent entirely new taxa.
3.2.2. Depth of Coverage in the Intesti Clusters
It was found that the weighted average depth of coverage varied considerably between clusters,
indicating a different abundance of those clusters within the cocktail (compare Figure 2). D6 and D12
as well as the Proteus phage cluster were found to be particularly abundant with an average depth of
coverage greater than 150ˆ. In contrast, the clusters D3, D4, D5, D8, D11, D14, D17 and D18 had a
very low average depth of coverage of 10ˆ or less.
Furthermore, we observed that many clusters exhibited some degree of variation in the depth of
coverage between their member contigs, evident by the weighted standard deviation, which is shown
as error bars in Figure 2. Upon inspection, we found that this was generally caused by a few contigs
with a very different depth from the rest (compare supplementary Figure S1). We reason that those
contigs can be explained by one of the following two scenarios.Viruses 2015, 7, page–page 
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Figure 2. Comparison of the weighted mean of the depth of coverage between clusters in the Intesti 
sample. The weighted standard deviation is depicted as error bars. Note that cluster D2 is composed 
of only one contig and the standard deviation is therefore not applicable. It can be seen that the 
depth varies greatly between clusters, reflecting the different abundances of the represented phage 
types in the cocktail. 
In a sufficiently closely related cluster, most of the common genome will assemble into a few 
long contigs with a high depth of coverage. The parts that differ between phages in the cluster, 
however, assemble into contigs that have a much lower depth. In that case, the depth of coverage is 
proportional to how common the module represented by that contig is within the cluster. Low 
coverage contigs may also be variants of the more common sequence contained in the high 
coverage contigs. Contrary to that, in a less closely related cluster, the parts of the phage genome 
that are shared can assemble into a few chimeric contigs instead of being placed in their respective 
genomes, causing those contigs to have excess coverage compared to the rest. 
Furthermore, we looked at the abundances of the phage families by summing the reads 
mapped to all clusters inferred to be Myoviridae, the same for Podoviridae and Siphoviridae. Reads 
mapping to contigs not assigned to a cluster are counted as unknown family. Doing that, we observed 
35% Myoviridae, 15% Podoviridae and 32% Siphoviridaein the reads. On top of that, 18% of the total 
reads are of unknown family. Observe that those fractions refer to reads that are quality trimmed 
but not redundancy reduced. When doing the same procedure with redundancy reduced reads, the 
fractions change to 41% Myoviridae, 16% Podoviridae, 29% Siphoviridae and 14% unknown family. 
3.2.3. Depth of Coverage in the Host-Amplified Samples and Comparison of Phage Clusters 
between Samples 
After performing contig grouping in the host-amplified samples, we examined each clusters’ 
highest scoring hits to phage in the non-redundant nucleotide collection and compared to the 
highest scoring hits in the Intesti clusters. Based on that, we identified clusters across samples that 
appeared to be synonymous. Using the ratio of the depth of coverage in the host amplified sample 
to the depth of coverage in the non-amplified Intesti sample, we were able to identify the infecting 
clusters since those experienced a great rise in coverage, up to 1000-fold (compare Table 3). All of the 
samples show significant amplification in only a few of the clusters. D14 was able to infect E. coli as 
well as both Shigella species, which is concurrent with the notion that those two species are closely 
related [38]. The two Shigella species tested were found to be susceptible to the same two clusters 
D14 and D15. Both of those appeared to be relatives of Escherichia or Enterobacteria phages. The 
Enterococcus and Salmonella samples shared two infecting clusters, namely D18 and F2. The authors 
are doubtful of the truth of this result, as Enterococcus is Gram positive and Salmonella Gram 
negative. It has therefore been removed. 
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Figure 2. Comparison of the weighted mean of the depth of coverage between clusters in the Intesti
sample. The weighted standard deviation is depicted as error bars. Note that cluster D2 is composed
of only one contig and the standard deviation is therefore not applicable. It can be seen that the depth
varies greatly between clusters, reflecting the different abundances of the represented phage types in
the cocktail.
In a sufficiently closely related cluster, most of the common genome will assemble into a few
long contigs with a high depth of coverage. The parts that differ between phages in the cluster,
however, assemble into contigs that have a much lower depth. In that case, the depth of coverage
is proportional to how common the module represented by that contig is within the cluster. Low
coverage contigs may also be variants of the more common sequence contained in the high coverage
contigs. Contrary to that, in a less closely related cluster, the parts of the phage genome that are
shared can assemble into a few chimeric contigs instead of being placed in their respective genomes,
causing those contigs to have excess coverage compared to the rest.
Furthermore, we looked at the abundances of the phage families by summing the reads mapped
to all clusters inferred to be Myoviridae, the same for Podoviridae and Siphoviridae. Reads mapping
to contigs not assigned to a cluster are counted as unknown family. Doing that, we observed 35%
Myoviridae, 15% Podoviridae and 32% Siphoviridae in the reads. On top of that, 18% of the total reads
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are of unknown family. Observe that those fractions refer to reads that are quality trimmed but not
redundancy reduced. When doing the same procedure with redundancy reduced reads, the fractions
change to 41% Myoviridae, 16% Podoviridae, 29% Siphoviridae and 14% unknown family.
3.2.3. Depth of Coverage in the Host-Amplified Samples and Comparison of Phage Clusters
between Samples
After performing contig grouping in the host-amplified samples, we examined each clusters’
highest scoring hits to phage in the non-redundant nucleotide collection and compared to the highest
scoring hits in the Intesti clusters. Based on that, we identified clusters across samples that appeared
to be synonymous. Using the ratio of the depth of coverage in the host amplified sample to the depth
of coverage in the non-amplified Intesti sample, we were able to identify the infecting clusters since
those experienced a great rise in coverage, up to 1000-fold (compare Table 3). All of the samples show
significant amplification in only a few of the clusters. D14 was able to infect E. coli as well as both
Shigella species, which is concurrent with the notion that those two species are closely related [38].
The two Shigella species tested were found to be susceptible to the same two clusters D14 and D15.
Both of those appeared to be relatives of Escherichia or Enterobacteria phages. The Enterococcus and
Salmonella samples shared two infecting clusters, namely D18 and F2. The authors are doubtful of the
truth of this result, as Enterococcus is Gram positive and Salmonella Gram negative. It has therefore
been removed.
Table 3. Depth of coverage ratio of host-amplified samples to the Intesti sample. Combinations with a
ratio greater than 1.0 are indicated by green background coloring. Those are thought to be the infecting
clusters, as they are more abundant in the host-amplified sample than in the original one. In the last
line is shown a phage cluster, which has not even been considered in the initial contig grouping of the
Intesti sample because of its small size of only 1346bp and low depth of coverage of only 2ˆ. It has,
however, been greatly amplified on P. aeruginosa strain PAO1.Results regarding the amplification on
Salmonella were inconclusive and therefore removed (see text).
Cluster E. coli Enterococcus P. aeruginosaPAO1
P. aeruginosa
PA0407
Shigella
flexneri
Shigella
sonnei Proteus
D1 0.03 0.00 0.00 0.00 0.02 0.00 0.00
D2 0.02 0.00 0.00 0.00 0.02 0.02 0.00
D3 0.30 0.00 0.00 22.29 0.10 0.00 0.00
D4 0.09 0.00 0.00 0.00 0.00 0.00 0.00
D5 0.11 0.00 0.00 0.00 0.00 0.00 0.00
D6 0.06 0.00 0.02 0.00 0.01 0.01 0.00
D7 0.05 2.57 0.00 0.00 0.02 0.00 0.00
D8 0.00 0.00 0.00 0.00 0.00 0.00 0.00
D9 0.04 0.00 0.00 0.00 0.02 0.00 0.00
D10 0.08 0.00 0.06 0.00 0.02 0.00 0.00
D11 0.13 0.13 0.00 0.00 0.00 0.00 0.00
D12 0.04 0.00 0.01 0.00 0.02 0.00 0.00
D13 0.05 0.05 0.00 0.00 0.04 0.00 0.00
D14 4.74 0.00 0.00 0.00 2.82 2.06 0.00
D15 0.04 0.00 0.00 0.00 4.97 9.84 0.00
D16 0.04 0.00 0.00 0.00 0.02 0.02 0.00
D17 47.17 0.00 0.00 0.00 0.00 0.00 10.01
D18 0.37 - 0.00 0.00 0.00 0.00 0.00
F1 0.00 0.00 1.47 0.00 0.00 0.00 0.00
F2 0.00 - 0.00 0.00 0.00 0.00 0.00
F3 0.00 0.00 0.00 0.00 0.00 0.00 0.00
F4 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proteus 0.04 0.00 0.02 0.00 0.00 0.01 0.12
* 0.00 0.00 1044.20 0.00 0.00 0.00 0.00
Note: The cluster marked by an asterisk (*) exists in the Intesti sample but has not been named due to its small
size and low depth (see table header).
BLAST-based comparison of those infecting clusters confirmed that they had a highly similar
sequence content to the clusters in the unamplified Intesti sample. With the exception of two clusters
amplified on P. aeruginosa PAO1, all others clusters were also of similar length when compared
between samples. F1, which is a fragment cluster in the Intesti sample, probably due to low
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abundance of those phages in the cocktail, nearly doubled in size to 22,920 bp on the PAO1 sample.
Despite this, about half of the sequence content of the F1 cluster in the Intesti sample is not represented
in the F1 cluster in the PAO1 sample. This indicates that F1 contains at least two distinct phages,
only one of which was amplified on PAO1, and this amplification enabled us to recover more of the
sequence of that phage. Furthermore, a new cluster of length 45,478 bp appeared in the PAO1 sample.
There is evidence of this cluster in the Intesti sample but was not treated as such due to its very small
size of 2392 bp and low depth of coverage of 1.78ˆ. Those results gave us more confidence that the
clusters defined by us are meaningful within the context of the cocktail.
Certain samples as e.g., the one amplified on E. coli also contained many different clusters in
low abundance. We believe that those phages are un-amplified phages carried over from the cocktail
when the host culture was infected. This is backed up by the fact that those clusters are synonymous
to Intesti clusters with a high depth of coverage and they are predominantly observed on those
host-amplified samples that featured a high read-count. Additionally, we found no indication that
the phage cluster we think to be a cluster of Proteus phages is capable of infecting the Proteus vulgaris
strain we used for amplification.
3.2.4. Gene Prediction and Functional Annotation in the Intesti Clusters
Gene prediction via GeneMark S on all contigs yielded a total of 3013 genes, 2577 of which
were predicted on the contigs that were assigned to a phage cluster and 258 of which were predicted
on unassigned contigs. 2864 genes (95%) had hits to NCBI’s non-redundant protein database and
annotation was retrieved from the top hits. It was however found to be of limited usefulness since
it is not standardized or focused on molecular function and often consists of unspecific terms such
as “hypothetical protein” or terms that only carry meaning within the genome they were originally
annotated in like “ORF3245”.
The RAST service, which was only used on the phage clusters, predicted 2408 genes. RAST uses
homology to genes in internal databases to retrieve annotation for the genes it calls. If this fails, the
annotation line “hypothetical protein” is given, though it can also be obtained by homology to a gene
already annotated in that way. A total of 893 genes (37%) carry the “hypothetical protein” annotation.
The overlap between genes predicted by RAST and GeneMarkS was 2230 genes.
Phages with the ability to integrate into the host’s genome are known to often carry genes
that increase their host’s fitness, among those resistance genes and virulence factors. For that
reason, integrase genes are generally regarded as undesirable in a phage therapy context [3]. The
full assembly of the cocktail’s metagenome was scanned against databases of resistance genes and
virulence genes using the ResFinder [34] and VirulenceFinder [35] tools. Neither scan detected
the presence of any known antimicrobial resistance genes or bacterial virulence factors for E. coli,
Enterococcus or Staphylococcus. Text mining the annotation for the terms “resistance” and “virulence”
returned seven genes in the RAST annotation, which are listed in Table 4. All but one of those
genes were also predicted by GeneMarkS, but differently annotated through BLAST. None of these
genes, however, seemed to be related to antibiotic resistance. A literature search determined that the
identified resistance genes were related to antiseptic resistance, which is not regarded as problematic
as antibiotic resistance [39] but also not desirable, especially in relation to the treatment of pathogens.
On the other hand, antiseptics like acridine and acriflavine have been shown to inhibit phage
activity [40,41], so the presence of resistance genes against those agents might be a tradeoff between
achieving the highest possible safety and retaining efficacy of the phage cocktail. Furthermore, one
of the most thoroughly lytic phages T4 can become resistant to inhibition of replication by acridine
and acriflavine [42].The two proteins annotated as “Phage virulence-associated protein” have tail
proteins among their closest BLAST hit, so it can be assumed that the term refers to virulence of the
phage towards its host and not to bacterial virulence factors.
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Table 4. List of genes potentially relevant for efficacy, found by text mining annotation results. The annotation column details whether the gene was found in the
annotation provided by RAST, by BLAST or both. If only one is named the other method either did not predict the gene or annotated it differently. Top BLAST
hit, query coverage as given by BLAST and percent identity as given by BLAST are only filled out if applicable. Most genes which were picked up for their RAST
annotation still have a BLAST hit description line, query coverage and percent identity values because that gene was also called by GeneMarkS. In any case, the
last two columns apply to the BLAST hit, but not necessarily to the hit in the RAST databases. The acridine resistance gene evidenced in D14 was not called by
GeneMarkS. If the gene was picked up for its BLAST annotation column 2 and 5 are identical.
Text Mining Term Description Line Part ofCluster Annotation by Top BLAST Hit Description Line
Query
Coverage
Percent
Positives
“virulence”
Phage virulence-associated protein D1 RAST ORF002 (Staphylococcus phage G1) 100% 100%
Phage virulence-associated protein D6 RAST putative adsorption associated tail protein (Enterococcus phage phiEF24C) 100% 95%
“resistance”
Acridine resistance D14 RAST - - -
Acriflavin resistance protein D3 RAST hypothetical protein PAK_P500103 (Pseudomonas phage PAK_P5) 100% 100%
Tellurium resistance protein TerD D5 RAST Phi92_gp172 (Enterobacteria phage phi92) 100% 100%
Tellurium resistance protein TerD D5 RAST Phi92_gp173 (Enterobacteria phage phi92) 100% 100%
Tellurite resistance protein D5 RAST Phi92_gp178 (Enterobacteria phage phi92) 100% 100%
“methyltransferase”
or “methylase”
DNA methylase D7 RAST/BLAST See “Description line” 100% 99%
DNA N-6-adenine-methyltransferase D8 RAST/BLAST See “Description line” 94% 90%
putative site specific DNA methylase D8 BLAST See “Description line“ 100% 99%
DNA methyltransferase D13 RAST/BLAST See “Description line” 100% 99%
putative DNA N-6-adenine
methyltransferase D10 RAST/BLAST See “Description line” 100% 99%
Dam methylase D8 BLAST See “Description line” 100% 100%
putative DNA adenine methylase D11 BLAST See “Description line” 100% 100%
putative DNA methyltransferase unassigned BLAST See “Description line” 100% 100%
DNA adenine methyltransferase D14 BLAST See “Description line” 100% 99%
putative DNA adenine methylase D11 RAST/BLAST See “Description line” 100% 97%
dCMPhydroxymethylase D14 RAST/BLAST See “Description line” 100% 100%
putative adenine methyltransferase D10 RAST/BLAST See “Description line” 100% 98%
DNA-cytosine methyltransferase D5 RAST Phi92_gp043 (Enterobacteria phage phi92) 100% 99%
Adenine-specific methyltransferase D5 RAST Phi92_gp155 (Enterobacteria phage phi92) 100% 99%
“integrase” Phage integrase D2 RAST/BLAST putative integrase (Escherichia phage KBNP1711) 100% 98%
Phage integrase D4 RAST/BLAST integrase (Enterobacter phage IME11) 100% 99%
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In addition to that, both annotation methods found two genes described as integrases in the
clusters D2 and D4. The D2 integrase had a sequencing coverage of 110ˆ, while the D4 integrase had
a sequencing coverage of 11ˆ. Both are congruent with to the coverage of the contigs they are placed
in. Furthermore, both genes showed high similarity to known integrase genes (see Table 4). However,
no statement can be made about the lysogenic or lytic nature of D2 and D4 phages since the integrity
of the lysogeny module was not tested in the lab.
Lastly, 10 genes described as “methyl-transferase” or “methylase” were found in RAST’s
annotation and 13 in the BLAST based annotation. We speculate that those genes may have a positive
influence on efficacy as they can enable the phage to evade restriction-modification based defense
systems as was detailed in a review by Samson et al. [33].
3.2.5. Evaluation of Sequencing Depth of the Cocktail
A rarefaction curve was made by assembling discreet fractions of the quality trimmed reads and
plotting the total assembly size vs. the fraction of reads used. The reasoning behind this was that if
the phage cocktail has been sequenced sufficiently deeply, the assembly size will converge as more
reads will add depth to the existing contigs instead of creating new ones. This behavior was indeed
observed (compare Figure 3). It can be seen that the rarefaction curve is not completely flattened
out, indicating that there may be rare phages not represented in the reads. Still, we reason that while
the sample is not sequenced to its entire diversity we have succeeded in covering the majority of the
phages present. Furthermore, when re-mapping reads to the finished assembly, 425,960 (97%) of the
440,392 reads map properly.
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Figure 3. Rarefaction curve of the Intesti sequencing sample. The curve appears to flatten out as the
percentage of reads used increases, indicating that the total assembly size is converging. This means
that the most common phages are well represented in the sequencing reads. Phages that are in low
abundance may not be adequately covered though.
3.3. Host Range Estimation
In a small scale in vitro experiment we found the host range of the cocktail to be largely consistent
with the specification given by the producer. Five to ten strains were tested for each pathogen listed
on the package. The exact number of strains tested and the fraction of strains found susceptible are
given in Table 5. The streaking tests confirmed that the cocktail was in principle able to cause lysis
of strains of all seven pathogens specified by the producer, albeit with differing specificity for the
different pathogens. The apparent low efficiency in lysis of Staphylococcus is due to the fact that only
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five of the ten tested isolates were S. aureus, of which all but one were susceptible. This can be seen in
Supplementary Table S2, which also contains a complete list of the specific strains tested.
Table 5. Fraction of the strains found to be susceptible for each pathogen tested. Observe that this is
only a small-scale experiment. All strains are part of an in-house collection.
Pathogen Susceptible Strains
Salmonella Enterica 10/10
Staphylococcus 5/10
Shigella 5/5
Pseudomonas Aeruginosa 5/7
E. coli 2/6
Proteus 3/5
Enterococcus 2/5
4. Discussion
4.1. Completeness and Accuracy of the Analysis
The rarefaction curve showed that the phages that are numerically in the majority appear to
be represented well in our data. However, there are indications that we have not seen the full
diversity of the batch of Intesti we analyzed. A phage cluster amplified on PAO1was barely even
present in the sequencing data of the cocktail, confirming that we potentially missed low abundance
phages. It is not clear which impact the abundance of a particular phage or phage cluster has on its
efficacy in the host, since specific amplification upon encountering the host is an important factor in
therapeutic applications.
It is the authors’ understanding that the library preparation we used favors dsDNA and the
vast majority of phages known today are indeed tailed dsDNA phages [4]. Nevertheless, we cannot
exclude the possibility that the cocktail contained ssDNA phages, especially since we introduced
a 5 kb size cutoff for contig groups. It is the authors’ experience, that contig groups smaller than
that may not be true clusters but rather shared modules. At a size smaller than 5 kb it is further
difficult to obtain an unambiguous attribution to a certain phage species or cluster of species due to
the aforementioned shared modules.
Intriguingly, the three clusters that contain the most common phages in the cocktail, namely D6,
D12 and the presumed Proteus phage cluster, are also those we know the least about, as they are
the ones most different from previously studied phages. For the presumed Proteus phage, it is not
even sure whether the two contigs form a single cluster, though each by itself is also very abundant
(compare depth of coverage and its standard deviation for the Proteus phage, Figure 2). We have
predicted the phages to belong to the Siphoviridae based on tail fibers, but it is not known what their
hosts are.
There is a possibility that some of the phage components in the cocktail derive from induction
of prophages in the propagating strains, which may explain the comparatively high prevalence of
Siphoviridae in the Intesti cocktail as well as the presence of lysogeny-related genes. This hypothesis
could not be tested since the propagating strains are proprietary and therefore not available.
4.2. Concerning the Synonymous Clusters and Amplification by Bacterial Hosts
It should be remarked that while the clusters infecting each host could be identified, it is not
possible to say whether or not all phages in a given cluster are causing infection. In the case of cluster
F1, of which only about half were amplified, the distinction was clear.
As was the case in the unamplified cocktail, the depth of coverage varied between contigs
belonging to the same phage cluster in the host-amplified samples. This could signify a bias for
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amplification of only certain parts of the cluster. On the other hand, chimeric vs. non-chimeric contigs
can also cause a variation in depth within a cluster (see Section 3.2.2).
Further, it turned out that the phage cluster we presumed to be Proteus specific, because of its
presence in the Proteus amplified sample and the fact that it did not have any hits to the nr nucleotide
database, did not actually cause infection in the Proteus vulgaris used in this study. It is therefore
unclear what kind of phage those two contigs represent and whether they should be clustered or
separate. The only evidence we have is that both of them have high depth of coverage values, which
are very similar to each other.
4.3. Comparison to Other Phage Cocktail Studies Employing Metagenomics
McCallin et al. published a metagenomic analysis of a Russian phage cocktail intended for
treatment of Escherichia coli/Proteus infections in 2013. Their methodology was somewhat different
and more extensive on the experimental side. Our study had its focus on bioinformatics and
specifically sequence analysis tools. These kinds of analyses are cheap and fast compared to
traditional lab techniques which is why we wished to test their suitability for phage cocktail analysis.
Naturally, they do not replace experimental evidence, however we think that by sequencing first
and employing bioinformatics prior to further lab work, we are able to gain insight and can design
lab experiments more efficiently. This will save time and money, especially as more tools are being
developed and databases grow more extensive.
In concordance with the results of McCallin et al., we also observed a great complexity within
the cocktail we analyzed. McCallin et al. found primarily Myoviridae (34%) and Podoviridae (24%) in
their cocktail. In comparison to that, the Intesti cocktail is also mainly composed of Myoviridae (35%),
but the second most abundant family was Siphoviridae, which were almost as abundant (32%).The
cocktail analyzed by McCallin et al. is, however, of very different scope, targeting solely E. coli and
Proteus, while the Intesti cocktail we analyzed targets a more broad spectrum of enteric bacteria.
In the Escherichia coli/Proteus targeting cocktail, McCallin et al. identified phages of the
Myoviridae subfamily Tevenvirinae and the genus Felixounalikevirus, plus phages of the proposed genus
of rv5-like virus, as well as the Podoviridae genera T7likevirus, SP6likevirus and N4likevirus. The
Intesti cocktail also contained clusters related to those two Myoviridae genera and subfamily and the
Podoviridae genera T7likevirus and SP6likevirus. The Intesti cocktail appears to have a greater diversity
of component phages compared to the Russian cocktail, which is in accord with its broader spectrum
of application. As the sequencing data produced in the study of McCallin et al. is not publically
available, the authors were unable to directly compare the phage clusters identified in the Intesti
cocktail to the phages identified in the Russian cocktail.
Neither study identified undesirable genes within the cocktail, but this is not a guarantee for
safety since the databases are not exhaustive. The two genes showing homology to integrases warrant
further investigation.
When McCallin et al. classified their redundancy removed reads with MEGAN, they observed
23% of reads without hits. In comparison, 25% of the redundancy reduced reads in our sample
mapped to contigs that could not be assigned, i.e., had no significant BLAST hits. However, McCallin
et al. compared their reads to the non-redundant protein collection and employed blastx, which has
a higher sensitivity. Therefore, the numbers cannot be directly compared between the two studies.
Furthermore, when looking at assembled contigs the total size of the contigs which had no database
hits, including the putative Proteus phage, was only 16% of the total assembly size, though many of
the clusters with known relatives appeared to have novel parts, as evidenced by the fact that their
coverage by their database references is not complete (compare Table 2).
Lastly, the metagenomics approach differed between our study and that of the Russian phage
cocktail in that we focused on assembling first and subsequently characterizing the contigs we had
obtained, while McCallin et al. did more characterization work on the read data and with mapping.
The main reason we chose direct de novo assembly of the full sample is that we were concerned about
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creating an artificial separation of the data by relying on mapping, especially since at least some
phages are known to be modular and to frequently switch modules, as illustrated for Staphylococcus
phages by Deghorain et al. [43]. Essentially, the focus of our study was on discovery.
4.4. Future Perspectives
One of the purposes of this study was to explore which types of sequence-based analysis are
suitable for phage cocktails and whether their results are useful. We hope to ignite discussion on how
the analysis of complex phage products can be done in the future.
5. Conclusions
The aim of this study was to identify and analyze the major components of the Intesti phage
cocktail. Returning to the question posed in the title, we conclude that a great amount of information
can be gained from examining a phage cocktail directly by metagenomic analysis, by relying on
databases and bioinformatics tools, though careful interpretation is crucial and not always straight
forward. Furthermore, we show that the kind of information presented in this article can be
gained without the need to separate and amplify individual phages prior to sequencing, which
may not always be possible especially when propagating strains are unavailable or unknown. As
databases grow more extensive with sequencing projects on the rise and more tools get developed,
we expect that the kind of bioinformatics analysis we employed in this study will grow more powerful
and accurate.
Acknowledgments: This work was supported by the Center for Genomic Epidemiology at the Technical
University of Denmark and funded by grant 09-067103/DSF from the Danish Council for Strategic Research.
The authors would like to thank Finn Kvist Vogensenof the University of Copenhagen for insightful discussions.
Furthermore, we would like to express our gratitude towards Nikoloz Nikolaishvili for providing us with the
sample of the Intesti phage cocktail.
Author Contributions: Mette V. Larsen conceived, designed and coordinated the project. Katrine G. Joensen
and Henrike Zschach performed the laboratory work. Katrine G. Joensen provided guidance for the laboratory
work. Barbara Lind hard performed the read mapping and depth of coverage analysis. Henrike Zschach
performed the rest of the data analysis. Henrik Hasman supplied bacterial strains and helped to interpret
experimental results. Ole Lund provided helpful comments from a more technical programming perspective.
Marina Goderdzishvili, Zemphira Alavidze, Irina Chkonia, Guliko Jgenti, and Nino Kvatadzeare the main
people responsible for developing and producing this current Intestiphage cocktail. They also aided in the
historical description of the development and applications of the Intestiphage cocktail. Elizabeth Kutter aided
extensively in the analysis and interpretation of the results and in the editing of the paper. Henrike Zschach wrote
the paper draft. Mette V. Larsen performed major editing on the paper and was the main senior supervisor.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the
decision to publish the results.
References
1. World Health Organization. Antimicrobial Resistance Global Report on Surveillance 2014; World Health
Organization: Geneva, Switzerland, 2014.
2. Lu, T.K.; Koeris, M.S. The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 2011, 14, 524–531.
[CrossRef] [PubMed]
3. Chan, B.K.; Abedon, S.T.; Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol.
2013, 8, 769–783. [CrossRef] [PubMed]
4. Hatfull, G.F. Bacteriophage genomics. Curr. Opin. Microbiol. 2008, 11, 447–453. [CrossRef] [PubMed]
5. Reardon, S. Phage therapy gets revitalized. Nature 2014, 510, 15–16. [CrossRef] [PubMed]
6. Harper, D.R.; Anderson, J.; Enright, M.C. Phage therapy: Delivering on the promise. Ther. Deliv. 2011, 2,
935–947. [CrossRef] [PubMed]
7. Kutateladze, M.; Adamia, R. Bacteriophages as potential new therapeutics to replace or supplement
antibiotics. Trends Biotechnol. 2010, 28, 591–595. [CrossRef] [PubMed]
6587
Viruses 2015, 7, 6570–6589
8. Kutter, E.; Borysowski, J.; Mie˛dzybrodzki, R.; Górski, A.; Weber-Da˛browska, B.; Kutateladze, M.
Clinical phage therapy. In Phage Therapy: Current Research and Applications, 1st ed.; Borysowski, J.,
Mie˛dzybrodzki, R., Górski, A., Eds.; Caister Academic Press: Poole, UK, 2014; pp. 253–284.
9. Kutter, E.; de Vos, D.; Gvasalia, G.; Alavidze, Z.; Gogokhia, L.; Kuhl, S.; Abedon, S.T. Phage therapy in
clinical practice: Treatment of human infections. Curr. Pharm. Biotechnol. 2010, 11, 69–86. [CrossRef]
[PubMed]
10. Abedon, S.T.; Kuhl, S.J.; Blasdel, B.G.; Kutter, E.M. Phage treatment of human infections. Bacteriophage 2011,
1, 66–85. [CrossRef] [PubMed]
11. Sulakvelidze, A.; Alavidze, Z.; Morris, J.G. Bacteriophage therapy. Antimicrob. Agents Chemother. 2011, 45,
649–659. [CrossRef] [PubMed]
12. Bruttin, A.; Brüssow, H. Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage
therapy. Antimicrob. Agents Chemother. 2005, 49, 2874–2878. [CrossRef] [PubMed]
13. Sarker, S.A.; McCallin, S.; Barretto, C.; Berger, B.; Pittet, A.-C.; Sultana, S.; Krause, L.; Huq, S.; Bibiloni, R.;
Bruttin, A.; et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.
Virology 2012, 434, 222–232. [CrossRef] [PubMed]
14. Wright, A.; Hawkins, C.H.; Anggård, E.E.; Harper, D.R. A controlled clinical trial of a therapeutic
bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary
report of efficacy. Clin. Otolaryngol. 2009, 34, 349–357. [CrossRef] [PubMed]
15. Rhoads, D.D.; Wolcott, R.D.; Kuskowski, M.A.; Wolcott, B.M.; Ward, L.S.; Sulakvelidze, A. Bacteriophage
therapy of venous leg ulcers in humans: Results of a phase I safety trial. J. Wound Care 2009, 18, 237–243.
[CrossRef] [PubMed]
16. McCallin, S.; Sarker, S.A.; Barretto, C.; Sultana, S.; Berger, B.; Huq, S.; Krause, L.; Bibiloni, R.; Schmitt, B.;
Reuteler, G.; et al. Safety analysis of a Russian phage cocktail: From metagenomic analysis to oral
application in healthy human subjects. Virology 2013, 443, 187–196. [CrossRef] [PubMed]
17. Brüssow, H. What is needed for phage therapy to become a reality in Western medicine? Virology 2012, 434,
138–142. [CrossRef] [PubMed]
18. Breitbart, M.; Salamon, P.; Andresen, B.; Mahaffy, J.M.; Segall, A.M.; Mead, D.; Azam, F.; Rohwer, F.
Genomic analysis of uncultured marine viral communities. Proc. Natl. Acad. Sci. USA 2002, 99,
14250–14255. [CrossRef] [PubMed]
19. D’Herelle, F. The Bacteriophage; Williams & Wilkins Company: Baltimore, MD, USA, 1922.
20. Mikeladze, C.; Nemsadze, E.; Alexidze, N.; Assanichvili, T. Sur le traitement de la fievre typhoide et des
colites aigues par le bacteriophage de d'Herelle. La Médecine 1936, 17, 33–38. (In French).
21. Chanishvili, N. A Literature Review of the Practical Application of Bacteriophage Research; Nova Science
Publishers: New York, NY, USA, 2012.
22. Kuhl, S.J.; Mazure, H. d’Hérelle. Preparation of Therapeutic Bacteriophages, Appendix 1 from:
Le Phénomène de la Guérison dans les maladies infectieuses: Masson et Cie, 1938, Paris—OCLC 5784382.
Bacteriophage 2011, 1, 55–65. [CrossRef]
23. Andrews, S. FastQC—A Quality Control Tool for High Throughput Sequence Data. Available online:
http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/ (accessed on 1 February 2015).
24. Schmieder, R.; Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011,
27, 863–864. [CrossRef] [PubMed]
25. Laserson, J.; Jojic, V.; Koller, D. Genovo: De novo assembly for metagenomes. J. Comput. Biol. 2011, 18,
429–443. [CrossRef] [PubMed]
26. Zerbino, D.R.; Birney, E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs.
Genome Res. 2008, 18, 821–829. [CrossRef] [PubMed]
27. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol.
1990, 215, 403–410. [CrossRef]
28. Deurenberg, R.H.; Stobberingh, E.E. The evolution of Staphylococcus aureus. Infect. Genet. Evol. 2008, 8,
747–763. [CrossRef] [PubMed]
29. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics
2009, 25, 1754–1760. [CrossRef] [PubMed]
6588
Viruses 2015, 7, 6570–6589
30. Aziz, R.K.; Bartels, D.; Best, A.A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.;
Glass, E.M.; Kubal, M.; et al. The RAST Server: Rapid annotations using subsystems technology.
BMC Genom. 2008, 9. [CrossRef] [PubMed]
31. Besemer, J. GeneMarkS: A self-training method for prediction of gene starts in microbial genomes.
Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 2001, 29, 2607–2618.
[CrossRef] [PubMed]
32. Lobocka, M.; Hejnowicz, M.S.; Gagala, U.; Weber-Da˛browska, B.; Wegrzyn, G.; Dadlez, M. The first step
to bacteriophage therapy: How to choose the correct phage. In Phage Therapy: Current Research and
Applications; Borysowski, J., Mie˛dzybrodzki, R., Gorski, A., Eds.; Caister Academic Press: Norfolk, UK,
2014; pp. 23–67.
33. Samson, J.E.; Magadán, A.H.; Sabri, M.; Moineau, S. Revenge of the phages: Defeating bacterial defences.
Nat. Rev. Microbiol. 2013, 11, 675–687. [CrossRef] [PubMed]
34. Zankari, E.; Hasman, H.; Cosentino, S.; Vestergaard, M.; Rasmussen, S.; Lund, O.; Aarestrup, F.M.;
Larsen, M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67,
2640–2644. [CrossRef] [PubMed]
35. Joensen, K.G.; Scheutz, F.; Lund, O.; Hasman, H.; Kaas, R.S.; Nielsen, E.M.; Aarestrup, F.M. Real-time
whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic
Escherichia coli. J. Clin. Microbiol. 2014, 52, 1501–1510. [CrossRef] [PubMed]
36. Santos, S.B.; Kropinski, A.M.; Ceyssens, P.-J.; Ackermann, H.-W.; Villegas, A.; Lavigne, R.; Krylov, V.N.;
Carvalho, C.M.; Ferreira, E.C.; Azeredo, J. Genomic and proteomic characterization of the broad-host-range
Salmonella phage PVP-SE1: Creation of a new phage genus. J. Virol. 2011, 85, 11265–11273. [CrossRef]
[PubMed]
37. Schwarzer, D.; Buettner, F.F.R.; Browning, C.; Nazarov, S.; Rabsch, W.; Bethe, A.; Oberbeck, A.;
Bowman, V.D.; Stummeyer, K.; Mühlenhoff, M.; et al. A multivalent adsorption apparatus explains the
broad host range of phage phi92: A comprehensive genomic and structural analysis. J. Virol. 2012, 86,
10384–10398. [CrossRef] [PubMed]
38. Zuo, G.; Xu, Z.; Hao, B. Shigella strains are not clones of Escherichia coli but sister species in the genus
Escherichia. Genom. Proteom. Bioinform. 2013, 11, 61–65. [CrossRef] [PubMed]
39. Sheldon, A.T. Antiseptic “resistance”: Real or perceived threat? Clin. Infect. Dis. 2005, 40, 1650–1656.
[CrossRef] [PubMed]
40. Piechowski, M.M.; Susman, M. Acridine-resistance in phage T4D. Genetics 1967, 56, 133–148. [PubMed]
41. Kawai, M.; Yamada, S.; Ishidoshiro, A.; Oyamada, Y.; Ito, H.; Yamagishi, J.-I. Cell-wall thickness: Possible
mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 2009, 58,
331–336. [CrossRef] [PubMed]
42. Wang, F.J.; Ripley, L.S. The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects
of the tsL141 DNA polymerase allele on spontaneous mutagenesis. Genetics 1998, 148, 1655–1665. [PubMed]
43. Deghorain, M.; van Melderen, L. The Staphylococci phages family: An overview. Viruses 2012, 4, 3316–3335.
[CrossRef] [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open
access article distributed under the terms and conditions of the Creative Commons by
Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
6589

51 CHAPTER 8. PHAGE COMMUNITIES IN SEWAGE
8 Phage communities in sewage
Another aspect of phage therapy is very relevant yet often taken for granted -
where does one find good candidate phages? Traditionally, therapeutic phage
have often been isolated from human sewage, which has even been described
as the ideal isolation source by Lobocka et al [57].
In this study, we took the chance to examine a set of sewage samples that
was originally collected to track the spread of antimicrobial resistance genes
in different populations around the world. We wanted to use them to look
at phage communities in sewage instead. Luckily, the samples had been se-
quenced quite deeply as metagenomes which encouraged us to try and extract
phage sequences from them. Our findings showed those phages to be both
extremely diverse and contain a large amount of novel sequence, making for
exciting prospects in further studies.
This was also a good chance to test and in the process improve on MetaPhinder,
a tool used to identify phage contigs in metagenomic assemblies. MetaPhinder
was originally developed by Vanessa Jurtz during her Master’s thesis and is
now available in new version with extended output.
This study is still ongoing at the time of writing but I chose to include the
results so far since I believe it is a vital part of my PhD and thematically ties
into the other two papers.
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Abstract:  16 
Sewage, a highly competitive and diverse environment, is the primary isolation source for 17 
therapeutic phages. However, not much is known about sewage phage communities in different 18 
parts of the world. To address this, we have analyzed and compared the phage sequences found in 19 
81 sewage samples from 63 different countries. We also show that MetaPhinder-2.0 is a useful tool 20 
for identifying phage sequences in complex metagenomes and is not limited to finding homologs 21 
of known phages. Nearly all the phage communities contained a plethora of novel phage sequences 22 
independent of their geographic origin, underlining the undiscovered diversity of phages in 23 
sewage environment. However, crAssphage was almost universally present. By combining 24 
BLASTn hits to full contigs and a tBLASTn search against custom databases of conserved structural 25 
phage genes, we were able to assign taxonomic labels on family level to on average 25% of phage 26 
reads. We did not observe a clustering of samples by geographic region when comparing their 27 
genomic distances as measured by Mash. All samples were highly variable from each other. 28 
Further, when investigating the occurrence and coverage of known phages in sewage, we 29 
discovered intriguing patterns that corresponded to distinct phage families.  30 
Keywords: phage metagenomics; phage taxonomy; identification of phage contigs in complex 31 
environmental samples  32 
 33 
1. Introduction 34 
A large proportion of phages intended for therapy are isolated from sewage water which 35 
contains many of the major human pathogens and is considered an optimal isolation source [1]. In 36 
2015, Mattila et al published a feasibility study on this topic, finding that isolation of phages from 37 
sewage was successful identifying phages against Pseudomonas aeruginosa, Salmonella, extended 38 
spectrum beta-lactamase Escherichia coli, and Klebsiella pneumoniae. However, it remained 39 
difficult to isolate phages against vancomycin resistant Enterococcus and Acinetobacter baumannii 40 
as well as methicillin resistant Staphylococcus aureus [2]. 41 
 42 
Sewage is furthermore a highly competitive environment and a source of untapped 43 
biodiversity. For those reasons, there is a great need to learn more about sewage phage communities. 44 
However, due to their enormous sequence diversity and absence of common marker genes, phages 45 
are not readily identified in mixed metagenomic samples. This is especially true in samples that have 46 
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not been specifically treated to amplify viral DNA and remove bacterial and eukaryotic DNA. We 47 
here use an updated version of MetaPhinder [3], a tool that identifies phage contigs based on their 48 
cumulative average nucleotide identity (ANI) to a database on known phage genomes.  49 
 50 
In this study, we have investigated the phage components of sewage samples from around the 51 
world. We aim to address issues related to how similar samples are to each other, which proportion 52 
of phage contigs we are able to assign taxonomically and to what degree they display similarity to 53 
known phages. We further describe an update to MetaPhinder, a tool to identify phage contigs in 54 
metagenomic assemblies. 55 
2. Materials and Methods  56 
2.1 Sewage samples 57 
 58 
The Global Sewage Surveillance Project has the goal to surveil infectious diseases and 59 
antimicrobial resistance in human sewage around the world in order to determine the occurrence 60 
and burden of resistance in defined healthy human populations. To that end, the project 61 
coordinators have invited countries to collect two liters of urban sewage and send them to the 62 
National Food Institute at the Technical University of Denmark (DTU). For more information see 63 
http://www.compare-europe.eu/library/global-sewage-surveillance-project. The project is associated 64 
with COMPARE (http://www.compare-europe.eu/) and funded by the World Health Organization. 65 
 66 
In 2016 the Global Sewage Surveillance Project has collected a total of 81 samples of sewage 67 
from 63 different countries. For this study, we received the trimmed reads and full assemblies of 68 
those samples. We then identified and extracted the phage contigs in the assemblies for further 69 
analysis. 70 
2.2 Metadata 71 
 72 
The following metadata was available to us: 73 
Sample location (city, county, and GPS coordinates), sample region, sample site and sample 74 
date. We have only made use of the geographic metadata. Figure 1 shows a map of sample locations. 75 
 76 
 77 
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 78 
Figure 1. Sampling locations. For two samples only the country was available (marked with a grey 79 
star). El Paso, Texas was sampled four times (marked with a blue cross). The map was generated 80 
from GPS data using the webtool HamsterMap at http://www.hamstermap.com/custommap.html .  81 
 82 
2.3 Reference phage database 83 
 84 
We created a database of all available complete phage genomes to use as references. This was 85 
done by querying NCBI nucleotide with the search term ‘(phage [Title]) AND complete genome’ as 86 
well as downloading the entire database of phage genomes available on phantom.org Genomes from 87 
both sources were combined and homology reduced on 100% sequence identity to remove 88 
duplicates. The final database comprised 5477 genomes. All downloads were performed on 06. June 89 
2017. 90 
 91 
2.4 Sample preparation 92 
 93 
The samples were spun down and DNA was isolated using the DNA isolation QIAamp Fast 94 
DNA Stool protocol. Subsequently, the samples were sent to Oklahoma Medical Research 95 
Foundation for sequencing. Here, DNA was sheared to ~300 bp and the NEXTflex PCR-free 96 
DNA-seq library preparation kit was used for library preparation. The samples were multiplexed 97 
and sequenced on a HiSeq3000 using 2x150 bp paired end sequencing. Several of the samples were 98 
sequenced multiple times. 99 
 100 
2.5 Sequencing and assembly 101 
 102 
Raw sequencing data was quality trimmed and assembled with SPAdes 3.9.0 [4] using the 103 
-meta flag. For the samples that were re-sequenced several times reads from all sequencing rounds 104 
were used. 105 
 106 
2.6  Update to MetaPhinder, identification of phage sequences and phiX removal 107 
 108 
An updated version of MetaPhinder [3], from here on referred to as MetaPhinder-2.0, was used 109 
to identify phage contigs within the assemblies. The first version of MetaPhinder was based entirely 110 
on the cumulative average nucleotide identity (ANI) of a query contig to a phage database. ANI is 111 
hereby defined as: 112 
  113 
%𝐴𝑁𝐼 =  
∑ 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝐼𝐷𝑖∗𝑎𝑙𝑖
𝑁
𝑖=1
∑ 𝑎𝑙𝑖
𝑁
𝑖=1
∗ 𝑚𝑐𝑜𝑣            (1) 114 
 115 
where 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝐼𝐷𝑖  is the percent identity reported by BLASTn [5], 𝑎𝑙𝑖  is the alignment length 116 
and 𝑚𝑐𝑜𝑣 is the fraction of the query sequence covered by alignment to the reference. 𝑁 is the 117 
number of hits between query and the sequences in the reference database. The cumulative ANI 118 
considers hits from any phage genome in the database so long as the E-value of the hit is less or 119 
equal to 0.05. 120 
 121 
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In the updated version of MetaPhinder, we have removed the fixed classification threshold of 122 
1.7% ANI to the phage database. For the sewage dataset studied here we instead used 10% ANI, see 123 
results section. Further, we included a comparison of the query contig to a database of 5000 complete 124 
bacterial sequences from NCBI’s refSeq. Those bacterial sequences were split up into k-mers of 125 
length 16. In order to limit database size, we only retained k-mers with prefix ATG. We then 126 
removed all k-mers that occur in phages from this bacterial database. To run a comparison, query 127 
contigs are also split into k-mers of length 16 and prefixed with ATG. Since phage k-mers have been 128 
removed from the bacterial database, the k-mer query coverage becomes a direct measure of how 129 
much the query contig resembles a bacterium. 130 
 131 
The further analyses described below were run only on the contigs classified as phage by 132 
MetaPhinder-2.0. In addition to that, the phage contigs were compared to the sequencing control 133 
phiX174 by BLASTn [5] and contigs with greater than 99% identity were removed from the analysis.  134 
 135 
2.7 Fraction of phage DNA 136 
 137 
The fraction of phage DNA per sample was calculated by dividing the number of base pairs in 138 
phage contigs by the total number of base pairs in the assembly. 139 
2.8 Abundance estimation 140 
 141 
Following assembly and identification of phage contigs, trimmed reads were mapped to the 142 
contigs in order to estimate their abundance. In many of the following analysis, this abundance is 143 
expressed as percentage of phage associated reads mapped to a contig. 144 
 145 
2.9 Assigning taxonomic labels to phage contigs 146 
 147 
We employed two different strategies to assign taxonomic labels to the phage contigs. 148 
 149 
Firstly, contigs inherited labels on species as well as family level from their best hit in the 150 
database of reference phage genomes, if the average nucleotide identity (ANI) of contig to reference 151 
phage was equal to or higher than 80%. Note that this ANI value is only to the top hit phage, not the 152 
cumulative ANI to the full phage database. Some known phages such as crAssphage lack a phage 153 
family classification. In this case, a contig with the best hit to such a phage was assigned the family 154 
label ‘unknown’. This should be distinguished from the label ‘None’ which was assigned to contigs 155 
that did not have a reference with ANI >= 80%. With this approach, we identify matches to the full 156 
contig. 157 
 158 
Furthermore, labels on family level were predicted based on homology to four gene classes 159 
generally assumed to have a high conservation rate because they are essential for the correct 160 
functioning of the phage particle. These are capsid, baseplate and tail fiber encoding genes, as well 161 
as phage associated DNA polymerase genes. A database was constructed for each of those categories 162 
by firstly querying NCBI protein with the search term ‘capsid AND phage [Title]’ and setting the 163 
species filter to ‘Viruses’. The ‘capsid’ was replaced with ‘baseplate’, ‘tail fiber’ and ‘polymerase’ for 164 
the three other categories respectively. After that, to limit the computation load, databases were 165 
homology reduced by using cdhit [6] with a threshold of 90% homology on the shorter sequence. 166 
The phage family associated to each known gene was noted. Subsequently, we ran tBLASTn [5] of 167 
the databases against the phage contigs in each sample, retaining hits to known structural or 168 
polymerase genes if the percent positives was 50% or higher and the alignment length covered at 169 
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least 50% of the known gene. ‘Percent positives’ here refers to the percent of positively scoring 170 
amino acids in the alignment, i.e. amino acids that can be substituted for each other according to the 171 
BLOSUM matrix. This measure is more sensitive than ‘percent identical’ in amino acid space. 172 
Following this, a phage family label was assigned to the contig if the family label of each known 173 
gene found in the contig was identical.  174 
 175 
Lastly, we compared phage family labels obtained from both approaches and assigned 176 
consensus labels. This was done in the following manner: If only one of the two approaches yielded 177 
a taxonomic label this label was the consensus. If both approaches yielded a label and the labels were 178 
identical this label was the consensus. If both approaches yielded a label but the label differed, the 179 
consensus was set to ‘None’. 180 
 181 
2.10 Identification of known phages 182 
 183 
We further used the similarity function implemented as part of MetaPhinder (see equation 1) to 184 
compute ANI values of each known phage to each sample. Those values can be understood as a 185 
measure of how much of the known phage’s sequence was covered by the sample’s phage contigs, 186 
as opposed to how much of a contig could be explained by a known phage. 187 
 188 
2.11 Genomic distance estimation  189 
 190 
Mash [7] was used to calculate pairwise distances between the phage components of the 191 
samples. Mash is based on the MinHash principle which allows the reduction of large sequences to 192 
representative sketches and has been used to compare for instance webpages and images. In Mash, 193 
metagenomes are first reduced to sketches by splitting them into kmers, oligonucleotide stretches of 194 
length k. All kmers are then hashed with a hash function h. A sketch of size s contains the s smallest 195 
hashes returned by h. These genome sketches can then be compared by estimating their Jaccard 196 
index. See Ondov et al for more details. 197 
 198 
Since the amount of phage sequence identified in the samples differed considerably, all samples 199 
were randomly down sampled to 1100 kb phage sequence 100 times, and 100 all-against-all Mash 200 
distances were calculated from those subsets. We then used the average of the 100 Mash distances to 201 
obtain one distance for each pair. Average Mash distances within and between regions were further 202 
calculated as group averages with the following formulas. 203 
The average distance within one region is: 204 
 205 
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑤𝑖𝑡ℎ𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 =  
∑ 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒(𝑖,𝑗)𝑖<𝑗
𝑁
𝑖,𝑗=1
𝑁(𝑁−1)
2
       (2) 206 
 207 
where 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒(𝑖, 𝑗)𝑖<𝑗 is the distance between samples i and j with index i being less than 208 
index j. This is because the Mash distance is symmetric, meaning that 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒(𝑖, 𝑗) = 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒(𝑗, 𝑖). 209 
N is the number of samples within the region. The denominator of the fraction is the number of 210 
combinations. 211 
The average distance between two regions is: 212 
 213 
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑟𝑒𝑔𝑖𝑜𝑛𝑠 =  
∑ ∑ 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒(𝑖,𝑗)𝑀𝑗=1
𝑁
𝑖=1
𝑁∗𝑀
        (3) 214 
 215 
where N is the number of samples in region 1 and M the number of samples in region 2. 216 
 217 
Viruses 2016, 8, x 6 of 4 
 
3. Results 218 
 219 
3.1 Update of MetaPhinder 220 
 221 
During the process of finding phage contigs in the sewage samples we have updated the 222 
MetaPhinder method to MetaPhinder-2.0. This was done because we observed suspiciously high 223 
fractions of phage DNA when predicting with the original MetaPhinder. That first version operated 224 
with a classification threshold of 1.7% ANI to a phage database. This threshold was found by setting 225 
up a classification task where complete phage genomes and random length pieces of them were 226 
mixed with negative data consisting of bacterial, fungal, protozoa, non-phage virus and human 227 
sequences. For details see the publication by Jurtz et al [3].  228 
 229 
In this updated version, we wanted to insure that the contigs we identify as phage were more 230 
similar to phages than to bacteria and therefore included a k-mer based comparison to a bacterial 231 
database. All k-mers occurring in the phage database had been removed from the bacterial database 232 
to account for integrated prophages.  233 
 234 
In a metagenomics setting, it may not be advantageous to select a hard %ANI classification 235 
threshold, especially since the amount of known phage sequences is still very inadequate compared 236 
to their immense diversity. Instead, we opted to extend the output of MetaPhinder-2.0 to give the 237 
user as much phage-related information about a contig as possible. For this reason we have removed 238 
the classification column in MetaPhinder-2.0’s output and added the following columns: k-mer 239 
query coverage to bacteria, bacterial top hit, phage top hit, %ANI of the phage top hit, genome size 240 
of phage top hit, taxonomic lineage of phage top hit, taxID of phage top hit, host of phage top hit. 241 
The user is encouraged to review the presented information and decide on a classification fitting to 242 
their dataset. For the sewage data we found that requiring at least 10% ANI to the phage database 243 
and a higher ANI to phages than query coverage to bacteria gave good classification results 244 
 245 
The web service can be found at https://cge.cbs.dtu.dk/services/MetaPhinder/.  246 
3.2 Fraction of phage DNA 247 
 248 
We investigated the fraction of phage DNA present in each sample by dividing the total base 249 
pair count of the full assembly by the base pairs assigned to phage contigs. Doing so, we found that 250 
the fraction of phage DNA was between 0.83 and 5.33 percent. No influence of the geographic 251 
location on the size of the fraction of phage DNA was observed. 252 
 253 
 254 
Figure 2. Fraction of phage DNA as percent of total assembled base pairs assigned to phage contigs; 255 
displayed per sample and sorted by region. 256 
 257 
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3.3 Genomic distance estimation 258 
 259 
Mash [7] has been shown to be an effective tool for quickly estimating the genomic distances 260 
between complex, metagenomic samples based on overlapping kmers. However, a naive application 261 
of Mash directly on the recovered phage contigs proved to be heavily biased by the difference in the 262 
amount of phage DNA recovered from the different samples. We therefore randomly subsampled 263 
each sample to approximately 1100 kb a hundred times, calculated a hundred Mash distances and 264 
computed the average distance between samples from that data.  265 
 266 
We observed that the majority of samples were equally distant to each other with Mash 267 
distances between 0.2 and 0.3, as shown in the resulting heatmap in Figure 3. The four samples taken 268 
from El Paso, Texas are encoded as North America 8, 10, 11 and 12. They appear to form a small 269 
cluster. However, their pairwise distance is not lower than that of some other samples from distinct 270 
locations; compare e.g. Africa 6 and Africa 7.  271 
 272 
In addition to that, we have calculated average Mash distances within each region and between 273 
regions and observed that there was no substantial difference. This illustrates further that phage 274 
communities in samples from the same geographic region are on average not more similar to each 275 
other than samples from different regions. 276 
 277 
 278 
 279 
Figure 3. Heatmap of the average Mash distance between all samples. Rows and columns are sorted 280 
by region. There appear to be small clusters of higher similarity but overall all the samples are distant 281 
to each other. 282 
3.4 Assigning taxonomic labels 283 
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3.4.1. Full contig hits 284 
For taxonomic assignment, we first investigated how well the phage contigs in each sample 285 
were covered by alignment to known phages. To do so, we divided the contigs into five groups 286 
depending on the ANI to their closest reference. The groups were as follows: 0-20% ANI, 20-40% 287 
ANI, 40-60% ANI, 60-80% ANI and 80-100% ANI. We then plotted the distribution of those five 288 
groups for each sample, see Figure 4. In order to have a better representation of actual abundances, 289 
we used the percentage of phage reads mapped to the contigs instead of the percentage of contigs 290 
directly.   291 
 292 
We found that a large proportion (more than 50% in most samples) of the phage sequences 293 
found in sewage were very distant to all known phages, with their best reference yielding ANI 294 
values between 0 and 20%. The lowest ANI value identified was only 0.38%. Note, that it is possible 295 
for a contig to have a very low ANI to its best reference and still pass MetaPhinder-2.0’s classification 296 
threshold since MetaPhinder-2.0 accumulates hits across the whole phage database.  297 
 298 
We also observed that the proportions between the five groups of contigs did not vary 299 
considerably between samples. This means that sewage samples from Europe and North America 300 
do not contain an observably higher proportion of known phages than for example African and 301 
Asian samples. Notable exceptions to this are the samples Europe 19 and South America 3, in which 302 
respectively ~45% and ~30% of reads mapped to contigs with high similarity references. However, 303 
upon closer investigation it turned out that both these samples contained a low amount of 304 
assembled phage DNA. The phage contigs in Europe 19 amounted to only 137 kb and those in South 305 
America 3 to 307 kb sequence. 306 
  307 
 308 
 309 
Figure 4. Percent of reads mapped to contigs with 0-20% ANI, 20-40% ANI, 40-60% ANI, 60-80% ANI 310 
and 80-100% ANI to their respective best reference phage. The amount of reads with 0-20% ANI 311 
varied between 28 and 75% but is generally around 50% or higher. 312 
On the other hand, there was a small proportion of reads mapped to contigs that had very high 313 
similarity to their references (ANI values between 80-100%). We extracted these reference phages 314 
and investigated whether they were shared across several samples or unique to their sample. The 315 
results are displayed in Figure 5. It shows that most reference phages covering a contig with 80% 316 
ANI or higher only do so in one to five samples. One reference however is found in 73 out of 81 317 
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samples. This was crAssphage. The other phage found to be a good reference in 52 of the samples is 318 
Streptococcus phage phiNJ3.  319 
 320 
 321 
Figure 5. Histogram of the 314 references phages found to cover phage contigs with at least 80% 322 
ANI. The height of the bars corresponds to how many samples a reference occurred (with the 323 
above-stated ANI threshold). It can be seen that while most references are unique to their sample, 324 
two references are found in respectively 52 and 73 samples. They are Streptococcus phage phiNJ3 (in 325 
52 samples) and crAss phage (in 74 samples). 326 
3.4.2 Phage family labels based on conserved genes and consensus labels 327 
In an effort to obtain taxonomic labels for a larger proportion of contigs, we next compared the 328 
contigs against three databases of conserved structural phage genes as well as one database of 329 
phage-associated polymerase genes. The labels obtained in that way were on family level instead of 330 
species level. 331 
 332 
This strategy considerably increased the percentage of contigs with a taxonomic label for most 333 
samples, see green bars in Figure 6. Once again, we depict the percentage of phage reads mapped to 334 
these contigs to better account for abundance. This outcome was expected since the likelihood of 335 
finding a single gene match is intuitively greater than the likelihood of finding a match for a whole 336 
contig.   337 
 338 
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 339 
Figure 6. Percent of reads mapped to contigs with a phage family label using two different 340 
approaches as well as a consensus. Red: Taxonomic labels inherited from hits to the full contig, 341 
extracted from MetaPhinder-2.0 results with ANI >= 80%. Green: Taxonomic labels via matching to 342 
database of conserved structural genes. Blue: Consensus. 343 
In some samples however, the percent reads with a label actually decreased. This can for 344 
example be observed in sample Asia 6 and Europe 19. The reason for this is contigs mapped to a 345 
phage whose structural genes were at the time of writing not available in genbank and therefore not 346 
part of our database of conserved structural genes. One of these phages that features prominently in 347 
our data is crAssphage. Such contigs can only receive a taxonomic label from their best full contig 348 
hit.  349 
 350 
From this result, we decided to make a consensus of both approaches as described in the 351 
Methods part. Doing so further increased the percent of reads for which we could assign a 352 
taxonomic label to the point where we have labels on phage family level for at least 15% of phage 353 
reads in most samples and up to more than 40% in a few samples. This increase is largely due to 354 
complementary results, i.e. contigs that only obtained a label in one of the predictions but not the 355 
other.  356 
 357 
3.5 Identification of known phages 358 
In addition to trying to classify the phage contigs, we also sought to find out which of the 359 
known phages are present fully in the samples. For this, we once more used the similarity function 360 
of MetaPhinder-2.0 but swapped query and database. In that way, we calculated ANI values for 361 
each known phage to each sample, thereby describing how well the known phage is covered by the 362 
sample. The result is shown in Figure 7.  363 
 364 
This figure consists of a boxplot of the ANI values observed in all 81 samples per known phage. 365 
Only phages that were covered with an ANI of at least 50% in at least one sample are included. We 366 
have also color coded the phage labels on the y-axis by their families: Siphoviridae (red), Myoviridae 367 
(green), Podoviridae (blue) or unknown (grey). It can be seen that there appears to be pattern in the 368 
distribution of ANI values.  369 
 370 
At the top of the plot are crAssphage and Bas gut phage, a variation of crAssphage, which were 371 
present in almost every sample with an average ANI of 75%.  372 
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 373 
Below, we see a second group of phages that had an ANI between 0 and 10% in the majority of 374 
samples. However there are heavy tails to the right of the distribution, as evidenced by the long 375 
whiskers of the boxplots. Most of the phages in this group were members of the Siphoviridae. 376 
 377 
The third group of phages was not present in the majority of samples but create a curious wave 378 
pattern of eight lines at between 3 and 65% ANI. Each of these lines was one sample, which we have 379 
verified by coloring the ANI values belonging to the same sample in the same color (only for phage 380 
group three). The lines are caused by the fact that all of those phages had nearly the same ANI value 381 
to a certain sample. This group was dominated by Myoviridae phages. 382 
 383 
Finally, the fourth group of phages was also not present in most samples but if they were, their 384 
ANIs were quite high between 50 and 90%. In this group, members of all three phage families were 385 
found as well as a few phages of unknown family. 386 
 387 
 388 
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 389 
Figure 7. ANI of known phages to sewage samples. Each row corresponds to one known phage and 390 
shows a boxplot of that phage’s ANI values to each sewage sample, i.e. how well this phage is 391 
covered by alignment by the samples’ contigs. It can be seen that two versions of crAssphage are 392 
present in almost every sample with high ANI of at least 60%. Further, there appear to be three 393 
groups of phages that follow similar patterns. Phage labels are colored in accordance to their family: 394 
Myoviridae (green), Siphoviridae (red), Podoviridae (blue) or unknown (grey). Only phages with an 395 
ANI greater than 50% in at least one sample are shown.  396 
 397 
4. Discussion 398 
We have analysed the phage sequences found in metagenomics assemblies of 81 samples of 399 
sewage. We found that the phage communities differ considerably between samples and contain 400 
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many sequences that are either novel or distant from those of the phages currently available in 401 
public databases. 402 
 403 
This outcome is not unexpected. Metagenomic studies often find large fractions of sequences 404 
that do not map to the current databases, conventionally referred to as ‘biological dark matter’ [8]. 405 
Those sequences are attributed to uncultured bacteria, archaea and viruses, among them 406 
bacteriophages. This is in line with the finding that 85-99% of bacteria and archaea can currently not 407 
be grown in the lab [9]. Naturally, that means that also their phages cannot be cultivated and will 408 
thus be missing from the databases. Perez-Sepulveda et al for example reported that the majority of 409 
phages in marine environments are part of the sequencing dark matter, i.e. reads that cannot be 410 
mapped to known genomes [10]. 411 
 412 
We further found the fraction of phage DNA was between 0.83 and 5.33 as measured by the 413 
percent base pairs assigned to phage contigs. This is congruent with findings from Reyes et al who 414 
report that viral DNA makes up 2-5% of the total in most environments [11]. 415 
 416 
In respect to matching the phage contigs in the sewage sample to known phages, we found that 417 
only a small percentage of contigs map to a reference phage with a high %ANI and that most of 418 
those references are only found in few samples. This again ties in with the notion that the currently 419 
known phage sequences hardly even begin to cover the space of phage sequence diversity. 420 
CrAssphage is the major exception to that. This phage has already been described as highly 421 
abundant in the paper that describes its discovery by Dutilh et al [12]. This notion was further 422 
confirmed by studies on the human gut metagenome/phageome by Yarygin et al [13] and Manrique 423 
et al [14]. When looking at these results, we further need to consider that some phage contigs were 424 
quite short (<= 10 kb). This makes it statistically more likely to obtain an ANI of 80% or higher from a 425 
hit to only a short region in the reference phage.  426 
 427 
Our results on how well known phages are represented in the sewage samples showed a 428 
grouping of phages into four distinct patterns of ANI value distributions. Two of those groups are 429 
each dominated by a single phage family, though we are unsure how to interpret this result.  430 
 431 
Group three, dominated by Myoviridae, showed a wave-like pattern of ANI values far out from 432 
the mean of the distribution, which was close to 0. The pattern is probably caused by the phages in 433 
that group being closely related to each other. It is conceivable that the same group of contigs align 434 
equally well to each of those known phages, causing them all to have a very similar ANI value. 435 
 436 
 437 
Regarding the MetaPhinder update, we decided to remove a hard %ANI threshold, include 438 
more information on the phage top hit and report relatedness to bacteria as well. 439 
 440 
We reason that in an actual metagenome, the original %ANI threshold may be too permissive 441 
because of stray hits to genes shared for example between phages and bacteria. The presence of 442 
integrated prophages that are not annotated as such in bacterial genomes makes it quite difficult to 443 
differentiate between a phage contig and a bacterial contig especially with short contigs. We address 444 
this issue by comparing to a bacterial database that had all known phage k-mers removed from it. 445 
 446 
Further, while employing two different measures of comparison may seem counterintuitive we 447 
consider our approach to have merit. ANI and k-mer query coverage are not directly comparable, 448 
however both give an indication of genomic relatedness and have different advantages. The original 449 
MetaPhinder paper has shown that for phage classification %ANI is a better measure than k-mer 450 
query coverage. At the same time it is computationally very expensive to calculate %ANI of a contig 451 
to a large bacterial database, also since bacteria genomes are on average 10x times longer than phage 452 
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genomes. Using k-mers furthermore allowed us to efficiently remove phage-like sequences from the 453 
bacterial database without having to cut them out of the bacterial genomes. Since we are not 454 
interested in finding the best bacterial match to a contig but merely in estimating whether the contig 455 
is more similar to bacteria than phage, we argue that our divided approach is applicable and 456 
reasonable. 457 
  458 
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CHAPTER 9. HOST-GENOMIC DETERMINANTS OF PHAGE
SUSCEPTIBILITY IN S. AUREUS
9 Host-genomic determinants of Phage
susceptibility in S. aureus
Staphylococcus aureus, especially the methicillin-resistant strains, is a growing
global health concern and it is not surprising that considerable efforts have
been expended into research around phage therapy prospects for this important
nosocomial pathogen. The project presented here takes a closer look at one
of the principle aspects of phage therapy: What defines whether a given S.
aureus isolate is sensitive to a given phage?
To address this question we primarily needed three things: A set of clinically
relevant S. aureus isolates, a set of therapeutic phages and a mathematical
model of the interaction. Now this is a bioinformatics department, so we have
no lack of models but a distinct lack of biological organisms. It was a good
thing both Henrik Westh from Hvidovre Hospital and Ryszard Międzybrodzki
from the Hirszfeld Institute were happy to collaborate on this project and so
we were able to set up a wet-lab experiment and produce data fitting to our
research question.
With this targeted approach, we were able to identify 167 gene families in the
accessory genome of S. aureus that influence its susceptibility towards the ther-
apeutic phages used by the Hirszfeld Institute. This work is an important step
in the direction of well-informed therapy with monovalent phage preparations,
especially in a context where DNA sequencing of the causative agent of a severe
infection is set to become increasingly common. Methods such as ours can
aid in suggesting the appropriate phage tailored to the infecting bacterial strain.
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Abstract:  22 
Staphylococcus aureus is a major agent of nosocomial infections. Especially in methicillin-resistant 23 
strains, conventional treatment options are limited and expensive, which has fueled a growing 24 
interest in phage therapy approaches recently.  25 
We have tested the susceptibility of 207 clinical S. aureus strains to 12 (nine monovalent) different 26 
therapeutic phage preparations and subsequently employ linear regression models to estimate the 27 
influence of individual host gene families on resistance to phages. Specifically, we use a two-step 28 
regression model setup with a preselection step based on gene family enrichment.  29 
We show that our models are robust and capture the data’s underlying signal by comparing their 30 
performance to that of models build on randomized data. In doing so, we have identified 167 gene 31 
families that govern phage resistance in our strain set and performed functional analysis on them. 32 
This revealed genes of possible prophage or mobile genetic element origin, along with genes 33 
involved in restriction-modification and transcription regulators, though the majority were genes 34 
of unknown function. 35 
This study is a step in the direction of understanding the intricate host-phage relationship in this 36 
important pathogen with the outlook to targeted phage therapy applications. 37 
Keywords: phage therapy; bacterial phage resistance; regression modeling; MRSA 38 
 39 
1. Introduction 40 
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing health concern. It is the agent of 41 
many chronic bacterial infections in hospitals as well as in the community. Its resistance to 42 
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beta-lactamases severely limits treatment options, drives up the price for therapy, increases 43 
unwanted side effects and leads in many cases to worse clinical outcomes [1]. MRSA has been 44 
classified as a high priority pathogen on the 2017 list of antibiotic-resistant priority pathogens 45 
published by the World Health Organization [2]. Pathogens on this list are considered to pose the 46 
greatest threat to human health and to require urgently discovery and development of new 47 
antibiotics.  48 
 49 
Phage therapy has been proposed as a promising substitute for conventional antibiotics or a 50 
co-treatment in the treatment of multi-resistant bacterial pathogens [3]–[7]. Of the S. aureus phage 51 
known to date, most are temperate phages and belong to the Siphoviridae family [8]. Strictly lytic 52 
staphylococcal phages, as are typically required for therapy, are almost exclusively found in the 53 
Podoviridae and Myoviridae families [8]. 54 
 55 
The Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of 56 
Science in Wroclaw (HI) has been producing staphylococcal phages for therapeutic purposes since 57 
the seventies of the last century [9]. At present its collection consists of nine polyvalent 58 
staphylococcal phages (see: Materials and Methods) [10]. Those phages are used at the Phage 59 
Therapy Unit in Wrocław under the rules of a therapeutic experiment to conduct treatment of 60 
patients with chronic bacterial infections resistant to antibiotic therapy. The result have been 61 
encouraging as a good response has been observed in one third of patients [6]. 62 
 63 
However, in order for phage therapy to be efficient, it is necessary to have a good 64 
understanding of the specific interaction between phage and host. There are many strategies by 65 
which bacteria aim to evade predation by phages, which is a significant fitness factor and therefore 66 
under high evolutionary pressure. Some of the common general phage resistance mechanisms 67 
described are: modification of receptor sites to mask them against phage adsorption, 68 
restriction-modification systems, abortive infection systems, and CRISPR, to name a few 69 
[11].Restriction-modification is a two-part system composed of a methylase and a nuclease. The 70 
methylase introduces specific modifications on the organism’s DNA, thereby marking it is as self. 71 
DNA lacking those modifications, i.e. DNA of foreign origin, will be cleaved by the nuclease. 72 
Abortive infection occurs when the host cell recognizes the phage infection before completion of the 73 
phage’s reproductive cycle and initiates cell death, thereby preventing the phage from successfully 74 
creating progeny. CRISPR, an acquired bacterial defense system based on retention and subsequent 75 
recognition of fragments of foreign DNA[11], is not typically found in S. aureus [12]. 76 
 77 
S. aureus is known to have a rather large accessory genome that can make up as much as 25% of 78 
total genome size [8]. We therefore hypothesize in this study that S. aureus may be carrying accessory 79 
genes that encode various mechanisms that are geared toward phage resistance. Presence of such 80 
mechanisms may hamper the efficacy of phage therapy and it is therefore important to study these 81 
in order to perform optimization of phages used for treatment. 82 
 83 
Within the phage therapy community, it is being debated whether targeted single phages or 84 
cocktails composed of many phages with complementary host ranges are preferable for treatment 85 
[13]. Similar to broad-spectrum antibiotics, cocktails can be applied based on the symptoms of the 86 
patients, even though the infecting agent has not been isolated or characterized. On the other hand - 87 
like broad-spectrum antibiotics - this approach is likely to promote the development of resistance 88 
among the bacteria, both the ones causing the disease as well as by-standers. While it is expected that 89 
the use of targeted single phages would lead to far less development of resistance, successful 90 
treatment is dependent on detailed knowledge of the infecting agent coupled with a thorough 91 
understanding of the rules governing the phage-bacteria interaction. With the advent of cheap 92 
high-throughput sequencing methods, it is becoming increasingly common to determine the entire 93 
genome of infecting bacteria. 94 
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 95 
 In this study, we seek to elucidate the interactions between S. aureus and therapeutic phage 96 
preparations from the HI with a focus on single phages. To that end, we have tested the 97 
susceptibility of a collection of clinical MRSA isolates towards a collection of staphylococcal phage 98 
preparations from HI. Both the bacterial and phage collections we used are of great relevance to the 99 
phage therapy efforts, since the phages are either already in use or under consideration for 100 
experimental therapy in accordance with EU rules concerning compassionate use. Furthermore, the 101 
bacterial isolates were obtained from patients showing complicated nosocomial MRSA infections. 102 
This strain set represents the most prevalent clonal complexes observed in Denmark and may 103 
therefore not be representative of MRSA in different settings. 104 
 105 
The genomes of the bacterial strains were determined by whole genome sequencing and 106 
through employing a number of bioinformatics tools and machine-learning methods, we attempted 107 
to shed light on the genes of MRSA that play a role in determining the susceptibility or resistance 108 
towards phages. 109 
2. Results 110 
2.1 General results of the susceptibility testing 111 
A total of 207 MRSA strains were successfully tested for susceptibility to 12 phage preparations. 112 
The ratio of susceptible to resistant strains differed between the preparations. The percentage of 113 
sensitive strains ranged from 19% to 68% as can be seen in Table 1. We did not observe a large 114 
difference in efficacy between single phage preparations and mixtures. However, the efficacies of the 115 
different preparations are not directly comparable, since the titer of the phage preparations was not 116 
known. Instead the data presented in Table 1 may serve as an indication of whether or not there was 117 
sufficient positive and negative data to model the response. 118 
Table 1. Wet lab results of susceptibility testing. All phage preparations were tested at RTD, see 119 
Methods. MS-1, OP_MS-1 and OP_MS-1_TOP are mixtures of P4/6409, A5/80 and 676/Z. 120 
Phage 
preparation 
Percent sensitive Percent resistant 
1N/80 31.9% 68.1% 
676/F 50.7% 49.3% 
676/T 68.1% 31.9% 
676/Z 40.6% 59.4% 
A3/R 18.8% 81.2% 
A5/L 47.3% 52.7% 
A5/80 55.1% 44.9% 
P4/6409 37.7% 62.3% 
phi200/6409 44.0% 56.0% 
MS-1 33.8% 66.2% 
OP_MS-1 38.6% 61.4% 
OP_MS-1 TOP 39.6% 60.4% 
 121 
2.2 Genetic diversity of the strain collection 122 
Genetic distance between the MRSA strains was measured as 1-orthoANI (see Methods), and 123 
the result is depicted in form of a heatmap in Figure 1. This figure reveals a clear clustering of strains 124 
into groups with high identity, which follows the established clonal complexes and sequence types 125 
of S. aureus [14]. Based on this clustering, the strains were split into 5 partitions by visual inspection. 126 
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 127 
Partition 1 is substantially larger than the other four. This is due to the fact that the strains 128 
belonging to clonal complexes CC1, CC5, CC8 and CC80 have a high degree of identity to each other, 129 
compare large blue area in the upper left corner. Partitions 2 and 3 are well defined, encompassing 130 
CC22 and CC30 respectively. Partition 4 is made up of CC45 and CC398. CC398 is known for its 131 
prevalence in swine and cattle. Those strains are genetically distant from the rest of the strains 132 
though there is some degree of similarity to CC30. Partition 5 is composed of two clusters of related 133 
strains, as indicated in Figure 1. It contains a number of rarer CCs that also show a comparatively 134 
high distance in terms of orthoANI to the rest of the data set.  135 
 136 
 137 
Figure 1. All-against-all matrix of the genetic distance between the 207 MRSA strains used for this 138 
study. Distance is calculated as 1 - orthoANI and represented as color, where blue corresponds to 139 
lower and red corresponds to greater distance. The assignment of strains to partitions is marked on 140 
the right margin. 141 
 142 
2.3 Identification of gene families 143 
When predicting and clustering genes, we identified a total of 6419 gene families in the MRSA 144 
strain dataset. The distribution of these gene families across the 207 MRSA strains can be seen in 145 
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Figure 2, which shows a histogram of abundances of the gene families. 1777 gene families were 146 
identified in all 207 strains. These are the housekeeping genes. Furthermore, there is a heavy tail of 147 
gene families that were only observed in few strains (left side of the histogram). 148 
 149 
 150 
 151 
 152 
Figure 2. Abundance of gene families in the 207 strains. The peak depicted in the histogram is 153 
slightly higher than the number of housekeeping genes, 1.777, since the bin is wider than 1. 154 
 155 
2.4 Model construction and feature selection 156 
To identify gene families and construct a model capable of predicting the susceptibility of a 157 
MRSA strain to a given phage, a feature selection procedure based on enrichment scores and 158 
training of linear regression models was applied. In short, gene families were identified in a two-step 159 
procedure, first through a simple enrichment/association test, and second through a refinement step 160 
based on regression models combined with consistency constraints. 161 
 162 
2.4.1 Enrichment/association test 163 
For each cross validation fold, each gene family was assigned a p-value calculated from its 164 
corresponding contingency table estimated once from the original data and once from permuted 165 
data. When plotting the distributions of these p-values, illustrated in Figure 3 for the phage P4/6409, 166 
we can make several observations:  167 
 168 
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a) In most phage interactions there is a small tail of gene families with very low p-values, while 169 
the majority of gene families have non-significant p-values. 170 
 171 
b) In the permuted data, this tail vanishes as was to be expected. We also observed that the 172 
p-value distributions of phages 1N/80, A3/R and cocktail MS-1 resemble those of the permuted data 173 
much more than those of the real data (see Supplementary Figure S2). This indicates there were not 174 
enough positive examples of lysed strains to produce a signal that is distinguishable from random. 175 
 176 
  
 177 
Figure 3. Stacked histogram of p-value distributions across the five folds for the interaction with 178 
phage P4/6409. The density is shown instead of counts to account for fold 1 having a 100 times less p 179 
values compared to the other folds, since it does not include partition 1 and therefore did not need to 180 
be subsampled. Left: Real data. Right: Permuted data. 181 
 182 
Based on these observations, a p-value threshold of 0.01 or lower was implemented to admit 183 
gene families to the second round of feature selection by regression weights (for details see materials 184 
and methods). As seen in Table 2, the number of gene families picked by enrichment varied both by 185 
fold as well as by phage. In preparations 1N/80, A3/R and mix MS-1, the number of gene families 186 
picked was very low. Further, as expected, we find that no or only very few gene families are 187 
selected when analysing the permuted data. 188 
 189 
2.4.2 Refinement based on regression models 190 
In the second step of feature selection, we employed linear regression models fitted using Ridge 191 
regression. An internal cross validation was used to identify the optimal parameter for the Ridge 192 
penalty lambda. The optimal lambda penalty value across the different folds in the cross validation 193 
were comparable, indicating that the models are robust, though the size of the feature space varies 194 
(see Supplementary Figure S1). 195 
Antibiotics 2017, 6, x FOR PEER REVIEW  7 of 18 
Due to the 5-fold cross validation setup, each gene family was assigned 5 regression weights, 196 
which may be NA (not applicable) if the gene family was not chosen by enrichment for that fold. 197 
Weights can be either positive or negative. As we chose to model susceptibility as the positive 198 
outcome and resistance as the negative outcome, this means that positive weights point towards 199 
increased susceptibility, while negative weights point towards increased resistance.  200 
We next required that a gene family should have absolute regression weights greater than 0.01 201 
in at least three of the five partitions to have passed a second selection step. The number of gene 202 
families selected in this manner is listed per phage on the right side of Table 2. We term this the set of 203 
significant gene families for a certain phage. The number of significant gene families in interaction 204 
with phages 1N/80, A3/R and mix MS-1 was too small to train a final model. For the remaining 205 
phages, the amount of significant gene families varied between the different phages, though the sets 206 
were comparable in size with the smallest comprising 13 and the largest 80 gene families, see Table 207 
2. In total, there were 167 significant gene families. When performing the same procedure on 208 
permuted data, significant gene families could only be identified in four phages and a final model 209 
could only be trained for two. 210 
 211 
Table 2. Summary of the modelling results for real and permuted data. The ‘First model’ section 212 
reports the results of the first filtering procedure based of association analyses. The ‘Final model’ 213 
section gives the result of the second filtering procedure based on regression model fitting combined 214 
with consistency constraints. The AUC (area under the curve) is used as performance measure of the 215 
final model. The number of gene families selected given in the left part of the table is calculated as the 216 
average ± standard deviation across the five folds. If less than two gene families were selected based 217 
on regression weights, a final model could not be trained and the associated AUC is reported as NA 218 
(not applicable). 219 
First model Final model 
Real data Permuted data Real data Permuted data 
Phage 
Preparation 
No. of gene 
families selected 
by enrichment 
No. of gene 
families selected 
by enrichment 
No. of gene families 
selected on 
regression weights 
AUC 
No. of gene families 
selected on 
regression weights 
AUC 
1N/80 10 ± 16 0 2 NA 0 NA 
676/F 222 ± 144 0 45 0.78 0 NA 
676/T 361 ± 243 12 ± 11 79 0.87 3 0.63 
676/Z 112 ± 87 11 ± 14 31 0.72 4 0.61 
A3/R 13 ± 26 0 1 NA 0 NA 
A5/L 184 ± 124 0 37 0.8 0 NA 
A5/80 265 ± 148 0 80 0.78 0 NA 
P4/6409 200 ± 137 2 ± 4 61 0.79 0 NA 
phi200/ 
6409 
160 ± 138 0 56 0.79 0 
NA 
MS-1 6 ± 10 0 0 NA 0 NA 
OP_MS-1 86 ± 78 0 29 0.65 0 NA 
OP_MS-1_T
OP 
54 ± 52 1 ± 1 13 0.67 0 
NA 
 220 
 221 
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2.4.3 Final model 222 
Final models were next retrained including only the significant gene families passing both 223 
selection criteria as input features. Plots of the regression weights assigned by those final models 224 
showed the direction of weights to be consistent across folds, i.e. gene families are either found 225 
consistently to have positive or negative weights across most of the 5 partitions. This is depicted for 226 
the example of phage P4/6409 in Figure 4. 227 
 228 
 229 
Figure 4. Heat map of the regression weights for the final model of phage P4/6409. Columns are gene 230 
families, rows are cross validation folds. The color indicates the value and direction of each weight, 231 
with blue being strongly positive and red being strongly negative. Weights with low values are 232 
white. Results were comparable for other phages with the exception of 1N/80, A3/R and mix MS-1 233 
(see Table 2). 234 
Out of all the 167 gene families, in total 99 increased phage resistance, 63 increased phage 235 
susceptibility and five were ambiguous, meaning that they increased resistance to some phages but 236 
susceptibility to others. This confirms that the vast majority of significant gene families identified 237 
were consistent in their direction of influence. 238 
 239 
The definition of phage susceptibility we used in this analysis encompasses only the two 240 
highest lysis levels, namely confluent lysis and semi confluent lysis. We have re-run the modeling 241 
process including also the weakly sensitivity levels and found no difference in the modeling results. 242 
This is probably because intermediate sensitivity was rarely observed in our strain set (see 243 
Supplementary Table S4). 244 
 245 
2. 5 Functional annotation of the significant genes 246 
We further sought to characterize the function of the identified significant gene families by 247 
comparing them to the eggNOG database. The distribution of functional annotation terms identified 248 
for the full set of significant genes is shown in Figure 5, and shows that it was possible to identify a 249 
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match in eggNOG for only 60% of gene families. Most genes had either no hit in the eggNOG 250 
database or a hit to a NOG of unknown function.  251 
 252 
Case-by-case inspection of the functional annotation terms retrieved from both RAST and 253 
eggNOG for the 167 significant gene families identified 13 gene families that have terms directly 254 
related to phages, while another 18 were related either to other mobile genetic elements such as 255 
genomic islands and transposons or to processes associated to them such as transposase activity. 256 
Four additional gene families appeared to be part of restriction-modification systems and six had 257 
hits to transcriptional regulators. 258 
 259 
Out of these groups, only the gene families related to restriction-modification systems were 260 
found to consistently be associated with resistance to phage infection (as measured by the sign of the 261 
weights in the final model described earlier). The others groups encompass both gene families 262 
promoting resistance and families promoting susceptibility, further pointing to the complexity of the 263 
host-phage interaction. The full list of annotation terms for all significant gene families can be found 264 
in the Supplementary Table S2, together with the gene family’s average regression weight across the 265 
five cross validation folds per phage. 266 
 267 
 268 
 269 
Figure 5. Functional annotation categories of the eggNOGs matching to the set of significant genes 270 
across all nine phages. 271 
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 272 
To estimate whether this observed distributions of functional categories in the 167 significant 273 
gene families is different from what could be expected by chance, we estimated cumulative density 274 
functions for each eggNOG category from 10.000 random subsamples of 167 gene families drawn 275 
from the total set of 6419. From those, we calculated the likelihoods of observing each category by 276 
chance, and next evaluated if the probability of a given functional category estimated from the 167 277 
significant gene families is enriched or depleted compared to these random likelihood values. 278 
With a threshold of p=0.05, we find that categories ‘No hit’ and ‘Replication, recombination and 279 
repair’ are enriched, while ‘Post-translational modification, protein turnover, and chaperones’ and 280 
‘Inorganic ion transport and metabolism’ are depleted, see Supplementary Table S3. Further, it is 281 
conceivable that many gene families influencing the susceptibility are themselves phage-associated, 282 
as is evidenced in the functional annotation terms found for them. As phage genomes typically 283 
suffer from poor annotation [15], it is not surprising to find a high percentage of gene families 284 
without hits to the database and with hits to the ‘unknown function’. 285 
2.6 Overlap of significant gene family sets 286 
We further analyzed the overlap between the significant gene family sets found for each phage 287 
model. Figure 6 shows a histogram of the number of phage models where a given gene family was 288 
identified significant. It clearly presents that very few significant gene families are shared by many 289 
phage models and only one is shared by all nine. The majority of significant gene families have been 290 
observed in interaction with only one or two different phages. This in turn means that each of the 291 
phages we tested has a distinct and specific interaction with our bacterial strain set, since different 292 
genes in the bacterial host dictate whether infection will be successful. 293 
 294 
Further, the significant gene families of the three cocktails are not a linear combination of the 295 
sets identified for their component phages though there is a sizeable overlap (data not shown). 296 
 297 
 298 
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Figure 6. Histogram depicting the number of phage models where a given gene family was 299 
identified significant. 300 
 301 
There were four gene families found significant in at least eight phage models. They are listed 302 
in Table 4 along with their direction of influence and the annotation and category of their matching 303 
eggNOG, if any. Out of the four, three increase resistance to phage while one was ambiguous in its 304 
direction of influence. Two gene families had no hit in the eggNOG database and one was 305 
categorized as being of ‘unknown function’. We were therefore unable to deduce a possible function 306 
for them though they appear to be of great importance for phage susceptibility. One, cluster 3112, 307 
appears to be involved in regulation of transcription and signal transduction which may play a role 308 
in host takeover. There were no direct indications for how exactly those gene families effect their 309 
influence biologically but it is evident from the models that they do. 310 
 311 
Table 4. Predicted functions of the gene families found significant in interaction with eight or more 312 
phages. 313 
Gene family 
ID 
Times 
observed 
Increases eggnog 
annotation 
eggnog 
category 
cluster_1791 9 Resistance - No Hit 
cluster_389 8 Resistance - Function 
unknown 
cluster_3112 8 Resistance Transcriptional 
regulator 
Transcription 
cluster_3992 8 Ambiguous* - No Hit 
*This gene family always confers phage resistance except in one interaction in which it confers susceptibility. 314 
3. Discussion 315 
In this study we sought to model the host-genetic determinants of MRSA phage susceptibility 316 
with a two-step logistic regression model fitted via ridge regression. We succeeded in building 317 
models of acceptable performance for nine of the 12 tested phage preparations with AUCs ranging 318 
from 0.65 to 0.87. By doing so, we identified 167 host gene families that influence S. aureus’ 319 
interaction with those nine phages.  320 
 321 
Our dataset is with 207 observations rather small for this type of analysis, since there are many 322 
more covariates, i.e. gene families than observations. 323 
 We have addressed this by building a two-step model and including a filtering step based on 324 
p-values, thereby greatly reducing the number of covariates going into the analysis. As biological 325 
entities are shaped by evolution, the strains share some degree of relatedness, and the testing results 326 
are not completely independent observations. We have partitioned the data according to phylogeny 327 
in a way that ensures highly similar strains are located to the same partition. Doing that ensures that 328 
the observations we are aiming to predict are more independent from the ones we feed into the 329 
model during training. The partitioning was maintained at all steps, ensuring that data from highly 330 
similar strains was never used to predict the outcome.  331 
Furthermore, there was an uneven partitioning of the data due to a high percentage of strains 332 
from two very related sequence types, which may lead to bias. The challenge of uneven partitions 333 
was addressed by subsampling the oversized partition 1 so we could obtain a realistic distribution of 334 
p-values for the association of all genes to the observed phenotype. Lastly, our set of strains with its 335 
composition of clonal complexes is specific to Denmark [16] . It is not necessarily representative of S. 336 
aureus populations observed in different settings. 337 
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It should further be noted that our approach can only identify gene families that are part of the 339 
accessory genome, since the first selection step is based on differential abundance of those gene 340 
families in susceptible vs resistant strains. Furthermore, this analysis does not consider point 341 
mutations as far wild type and mutant version of a gene are more than 90% identical, since we have 342 
clustered genes into families with that threshold.  343 
 344 
Regarding the electronic gene family annotation, we were able to identify four gene families 345 
related to restriction-modification systems, all of which increased the resistance to phage as 346 
expected. 347 
Further, six of the significant gene families were related to transcriptional regulation and a 348 
multitude of gene families appear to be mobile elements of some kind. Those gene families had 349 
varying direction of influence. The findings fit well with the fact that phages try to shut down host 350 
transcription during take over, as well as with the interplay of integrated prophages and external 351 
phages, which can either complement each other or oppose each other. An integrated prophage may 352 
for example protect from further infection via a principle known as superinfection-exclusion [17]. 353 
 354 
For a large proportion of the significant gene families however, no hit could be found in the 355 
eggNOG database and of those that had a hit, the most common category was ‘Function unknown’. 356 
This may be due to the fact S. aureus has a large accessory genome that is made up mostly of different 357 
types of mobile genetic elements, among them prophages, highly diverse and not well characterized 358 
[8].  359 
We also found that there is only a minor overlap between the sets of significant gene families 360 
identified for different phages. This means that each phage had a different and specific interaction 361 
with the set of bacterial strains.  362 
 363 
Further, we found that more gene families promoted resistance than susceptibility. Among the 364 
four gene families that were found significant in interaction with at least eight different phages, 365 
three promote resistance and one was ambiguous (see Table 4). This overrepresentation of gene 366 
families promoting resistance was expected, since in our set-up resistance to phage can more easily 367 
be explained by a gain of function model, meaning the gaining of a defense mechanism of which 368 
there are plenty found in nature. We were unfortunately unable to identify the nature of the defense 369 
mechanism in most resistance promoting gene families from electronic annotation alone.  370 
 371 
Conversely, a gain in susceptibility linked to the presence of a certain gene family is more 372 
difficult to explain. The most ready interpretation is that this gene family somehow improves 373 
conditions for the phage. The observation can also be explained by integrated prophages which may 374 
become activated upon infection or stress caused by the adsorption of an external phage and then 375 
lyse their host after completing the lytic cycle. Since the products of the bacterial lysis by the phages 376 
were not sequenced, we cannot say whether the external, therapeutic phage or an integrated 377 
prophage is the agent of the lysis. Intriguingly, evidence of an interplay between virulence and 378 
phage resistance has also been shown. Laanto et al report that after co-cultivation with lytic phage, 379 
strains of the fish pathogen Flavobacterium columnare that have acquired phage-resistance have also 380 
lost their virulence compared to phage-sensitive paternal strains [18]. Similar observations have 381 
been made for S. aureus by Capparelli et al [19] , who show that phage-resistance is associated with 382 
reduced fitness. Accordingly, genes families found by us to increase phage susceptibility may also 383 
be associated with virulence and competitiveness. This is coherent with the origin of our strain set as 384 
clinical patient isolates. 385 
 386 
One of the current debates in phage therapy focuses on the issue of whether broad spectrum 387 
phage cocktails or monovalent phage preparations are preferable [13], [20] . Our approach is a step 388 
in the direction of characterizing the interplay between clinical strains of MRSA and single phage 389 
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preparations so that a well-targeted phage can be utilized for therapy. We have not observed an 390 
advantage of phage cocktails over the monovalent preparations they contain. This may be due to 391 
interference between the component phages as has for example been documented by Delbruck [21] 392 
and Adams [22]. 393 
 394 
We have shown that while our methodology does not have predictive power, allow for the 395 
association of the observed phenotype with the genetic background, thereby producing 396 
interpretable results that can be used for gene function discovery. This type of analysis, which 397 
combines phenotypic and whole genome sequencing (WGS) data can be used to identify genetic 398 
determinants of observed bacterial phenotypes in other settings as well. 399 
 400 
4. Materials and Methods  401 
4.1 Collection of clinical MRSA strains used for susceptibility testing 402 
The collection of 207 MRSA strains tested in this project as well as their whole genome 403 
sequences (WGS) were obtained from the Clinical Microbiology Department of Hvidovre Hospital, 404 
Denmark. The strains originate from patient samples. They were selected to represent a broad 405 
genetic diversity of the more than 5000 WGS MRSA from Hvidovre Hospital.  406 
 407 
Although no methicillin-sensitive (MSSA) strains were included in the study, we nonetheless 408 
chose MRSA strains of the spa-types that are common in MSSA infections. We included MRSA 409 
strains positive for PVL and containing mecC. All inclusion criteria are listed in a Supplementary file 410 
and the properties of selected isolates can be found in the Supplementary Table S1. 411 
4.2 Collection of phages used for susceptibility testing 412 
A total of 12 therapeutic staphylococcal phage preparations were used for susceptibility testing. 413 
They contain phages which are part of the proprietary collection of therapeutic phages used by the 414 
phage therapy unit of the Hirszfeld Institute of Immunology and Experimental Therapy of the 415 
Polish Academy of Science in Wroclaw (HI) [23]. Nine of the preparations are monovalent phage 416 
lysates (containing 1N/80, 676/F, 676/T, 676/Z, A3/R, A5/L, A5/80, P4/6409, or phi200/6409 phage). 417 
Crude phage lysates were prepared according to the modified method of Ślopek et al. [9] [citation]. 418 
Six of those phages (1N/80, 676/Z, A3/R, A5/80, P4/6409, and phi200/6409) were sequenced and 419 
confirmed to be obligatory lytic and belonging to a Twortlikevirus genus of a Spounavirinae subfamily 420 
of Myoviruses [24]. They were provided in routine test dilution (RTD) which is the highest dilution 421 
that still gives confluent lysis on the designated propagating strain of S. aureus [25]. Three others 422 
were equal mixtures of A5/80, P4/6409, and 676/Z phages prepared at the Institute of Biotechnology, 423 
Sera and Vaccines BIOMED S.A. in Cracow, Poland: MS-1 phage cocktail lysate containing each 424 
phage in a titer no less than 5×105 pfu/ml, OP_MS-1_TOP cocktail of purified phages suspended in 425 
phosphate buffered saline containing each phage at no less than 109 pfu/ml [26] [citation], and 426 
OP_MS-1 phage cocktail of the similar characteristics as OP_MS-1_TOP but containing up to 10% of 427 
saccharose as a phage stabilizer. 428 
 429 
4.3 Susceptibility testing procedure 430 
Testing for phage susceptibility was performed as described by Ślopek et al [27]. In short, 50 l 431 
of phage preparation was applied onto a fresh bacterial lawn from day culture and the results were 432 
assessed the next day following 6 hours incubation at 37C.  433 
Results were assessed according to a 7-point scale as described by Ślopek et al [27] and then 434 
further discretized into two levels: ‘susceptible’ and ‘resistant’. The ‘susceptible’ label was applied to 435 
the two strongest reactions, resulting in confluent or semi confluent lysis. According to standards 436 
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applied at the Bacteriophage Laboratory of the HI, those two levels enable the phage procurement 437 
for therapeutic phage preparation. All other weak reactions as well as a negative reaction and 438 
opaque lysis were regarded as 'resistant'. The full set of 207 strains was challenged with each of the 439 
12 phage preparations. We call the result of susceptibility testing to a preparation the ‘interaction’ of 440 
our strain set with said phage.  441 
 442 
We also build models using a modified division of the phage reaction including weakly 443 
susceptible levels (>20 independent plaques) in the definition of ‘susceptible’ and only including 444 
strongly resistant results (resulting in the negative reaction, opaque lysis or < 20 plaques) in the 445 
‘resistant’ label. Thereby, we investigated whether the split we imposed on the 7-scale phage typing 446 
results influenced our modeling results. 447 
 448 
4.4 Data Partitioning 449 
For the purpose of modelling the phage response from the genomic composition of the bacterial 450 
strains, the 207 MRSA strains were divided into five partitions. This division was based on the 451 
orthogonal average nucleotide identity (orthoANI) as described by Lee et al [28]. OrthoANI is 452 
suitable for creating a distance matrix, because it is a symmetric measure of distance, unlike the 453 
traditional ANI. Calculations were performed on all pairs of strains with the standalone tool OAT by 454 
Lee et al. Distances were subsequently calculated as 1 – orthoANI and a heat map was generated 455 
which can be found in Figure 1. 456 
 457 
The resulting heat map showed very clear clusters of closely-related sequences. Partitioning 458 
was therefore done by visual inspection. 459 
 460 
The partitions thus obtained were then used in a five-fold cross validation framework, i.e. four 461 
of them were combined into the training set and one was left out for testing. This process is repeated 462 
five times so that each partition is in turn the testing set. 463 
 464 
 465 
 466 
4.5 Identification of gene families 467 
The genetic makeup of the MRSA strains was analyzed by first predicting genes and 468 
performing functional annotation through the RAST service [29]. The predicted genes were then 469 
clustered with cd-hit [30] using a cutoff of 90% on global sequence identity, word size 5 and the -g 1 470 
option to cluster with the best match instead of the first match. This resulted in a total of 6.419 gene 471 
families in the 207 MRSA strains. 472 
 473 
Next, the feature space, i.e. the number of gene families included, was reduced by removing 474 
gene families with limited power for distinguishing susceptible from non-susceptible bacterial 475 
strains. This was done by constructing 2x2 contingency tables as shown in Table 3, and from these 476 
tables calculating a p-value to each gene family in each phage interaction using Fischer-Boschloo’s 477 
exact unconditional test. In contrast to the often used Fischer's, exact conditional test, 478 
Fischer-Boschloo’s is an exact unconditional test. In total sum fixed designs, unconditional test are 479 
always preferable to conditional tests for reasons detailed by Lydersen et al [31]. We then imposed a 480 
threshold of 0.01 on the p-value for the gene family to be admitted to the second step of modelling. 481 
 482 
 483 
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Table 3. Layout of the contingency tables used for analysis. The asterisk denotes the total sum fixed 484 
by design. 485 
 Susceptibility    
Presence of gene 
family 
susceptible resistant Sum 
present a1 b2 a+b 
absent c3 d4 c+d 
Sum a+c b+d n* 
1 Number of isolates that are susceptible to the phage currently 486 
looked at and in which the current cluster is present. 487 
2 Number of isolates that are resistant to the phage currently looked 488 
at and in which the current cluster is present.
  
489 
3 Number of isolates that are susceptible to the phage currently 490 
looked at and in which the current cluster is absent.
  
491 
4 Number of isolates that are resistant to the phage currently looked 492 
at and in which the current cluster is absent. 493 
Both the row and column margins sum to n. 494 
 495 
This first filtering step was performed inside the cross validation framework, so that the 496 
partition being tested was not included in this initial p-value based feature reduction. Due to the fact 497 
that the 2x2 tables were constructed from only the training set, some gene families in a given test set 498 
do not have a p-value associated. This specific situation arises when gene families are only present in 499 
one partition and that partition is left out of the training set. In these cases the gene family was 500 
assigned a p-value of NA (not applicable). 501 
4.6 Bootstrapping 502 
As can be seen in Figure 1, partition 1 is substantially larger than the other four partitions in the 503 
benchmark data, see 3.2 for further details. This potentially imposes a bias when calculating the 504 
association p-values, since these often will be driven solely by the data in partition 1. To amend that, 505 
a bootstrapping resampling procedure was applied to partition 1: When picking gene families based 506 
on a combination of partitions that includes partition 1, instead of including the full partition, a 507 
subsample of 25 strains used and was added to the other three partitions. From that data, we then 508 
created contingency tables and calculated p-values as described above. This procedure was repeated 509 
a 100 times, resulting in 100 p-values per gene family per phage interaction. We then imposed the 510 
condition that a gene family had to pass the p-value threshold of 0.01 in at least 90 of those to be 511 
selected. 512 
 513 
4.7 Model construction and feature selection 514 
While a strong p-value obtained, for instance, from a contingency table as described above is an 515 
indication, it is often not a conclusive proof of an actual association existing between the gene and 516 
the observed phenotype. For that, the gene needs to have predictive power towards the phenotype it 517 
is thought to be influencing. Therefore, we chose to model the phage response with a logistic 518 
regression model that was fitted using a Ridge regression. 519 
For each phage interaction, a logistic Ridge regression model was trained on four of the 520 
partitions and tested on the one left out partition using the gene families that has passed the 521 
association-based p-values criteria described above as input, and the binary susceptible/resistant 522 
annotations as target values. This was done five times for the five possible combinations of 523 
partitions. This five-fold cross validation framework allowed us to evaluate the model’s predictive 524 
potential and assess their robustness. 525 
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In this way, five models were constructed each with regression weights associated to each of the 526 
gene families. If a gene family had not been picked for that particular partition, it was assigned a 527 
weight of NA. We hypothesised that gene families with a high weight across many partitions drive 528 
the response to this particular phage. In order to verify this, we next trained and tested a second 529 
five-fold cross validated regression model with only the genes that 1) were significant according to 530 
the Fischer-Boschloo’s test (P ⪯ 0.01) and 2) had weights above 0.01 in at least three partitions in the 531 
first regression model. 532 
In order to verify that the set of genes we identified were indeed descriptive of the phage 533 
susceptibility and not an artifact of over-fitting, we repeated the model construction and feature 534 
selection with shuffled target values. That is, we randomly associated susceptibility outcomes and 535 
bacterial genomes, while keeping the ratio between susceptible and resistant as in the original data. 536 
We then re-ran the modelling, and evaluated the predictive performance and the number of 537 
predictive gene-families identified. 538 
 539 
4.8 Assignment of EggNOGs 540 
We further compared each gene family to the EggNOG database [32] by using the 541 
eggNog-mapper available on their webpage. EggNOG is a database of non-supervised orthologous 542 
groups (NOG) of proteins, in which each group has only one annotation term compiled from the 543 
integrated and summarized functional annotation of its group members. Each NOG is also part of a 544 
broader functional category. This allows for the quick and efficient assignment of functions for 545 
predicted genes by finding their matching NOG. 546 
 547 
After identifying a set of significant gene families (see 2.7), the prevalence of each functional 548 
category in that set was calculated. We also extracted 10.000 random subsamples of the same size 549 
from the full set of genes and used these data to establish an estimated cumulative density function 550 
(eCDF) for the prevalence of each category. 551 
 552 
Supplementary Materials: The following are available online at www.mdpi.com/link: Details of inclusion 553 
criteria for MRSA strains. Figure S1: Plot of the cumulative mean square error of the inner cross validation vs 554 
strength of the ridge penalty. Figure S2: P-value distributions of gene enrichment analysis on phage 555 
preparations 1N_80, A3_R and cocktail MS-1. Table S1: List of MRSA strains included in the test set. Table S2: 556 
List of all significant gene families along with their functional annotation terms. Table S3: Probabilities of 557 
observing a given prevalence per functional category based on the cumulative density function. Table S4: 558 
Detailed phage typing results. 559 
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10 Conclusion and outlook
The vast increase of antimicrobial resistance seen in recent years poses a
serious threat to public health and - if unresolved - may lead to a future where
common bacterial infections will once again be deadly. Phage therapy is one
of the most promising alternatives to antibiotics and accordingly considerable
time and effort have been invested into the field.
The focus of my PhD has been to investigate how genomics and machine
learning techniques can be used to further the understanding of therapeutic
phages and the phage-host interaction. To do so, different aspects of phage
therapy research were explored. It started with the characterization of an
already existing phage cocktail, then moved on to investigate determinants
of phage susceptibility in the host-genome. Lastly, the diversity of phages
present in sewage, the major isolation source of therapeutic phages, was
explored. To maintain the flow of thought, the chronologically last project
(concerning phages in sewage) was presented in this thesis as the second project.
In the first project of this PhD, the long-used and highly clinically relevant
INTESTI phage cocktail has been sequenced and analyzed. We found that
there are at least 23 different phage types in the cocktail, 20 of which showed
considerable similarity to known phages while 3 were largely novel.
One of the main conclusions of this paper was, that the different phage types
were present in vastly different abundances in the cocktail. This could be a
consequence of the way the cocktail is produced. However, since the INTESTI
cocktail has been in use successfully for many years, the uneven composition
may also be a feature. Different phage types exhibit different levels of stability,
efficiency of adsorption and burst size. Some phages may therefore require a
higher multiplicity of infection that others to be effective. This has implications
for companies and research laboratories seeking to produce their own cocktail.
It should be verified whether even or uneven ratios of the component phages
produce the best results.
The study furthermore included an amplification experiment in which in-house
bacterial strains that had proven susceptible to the cocktail were infected
and subsequently their lysates sequenced to discover which phages in the
cocktail had been amplified. It was found that a phage contig which was
barely present in the sequencing data of the full cocktail corresponded to a
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group of contigs with high coverage in the lysate of Pseudomonas Aerugi-
nosa PAO1. This result illustrates the usefulness of a highly diverse cocktail
since even component phages in low abundance can unfold their potential
upon meeting their host. However, in current phage therapy efforts in the
Western world, phage cocktails are typically of low complexity because drug
regulatory authorities require approval for every component phage. To re-
solve this question, there is a need for more studies investigating whether or
not high-complexity phage cocktails are preferable from a clinical point of view.
In the second project, phage communities present in sewage samples were
compared to known phages in databases as well as to each other. It was found
that typically more than 50% of phage contigs in a sample had no close known
relative. This underlines both a great need for more environmental phage
studies as well as the enormous genetic potential still hidden in even mundane
environments like city sewage.
The study also showed that the phage communities of different sewage samples
were quite distinct from each other. This pairwise genomic distance, based on
shared k-mers, was astonishingly constant and did not appear to correlate with
whether or not the samples were from a similar geographic location. At the
same time, the majority of samples contained crAssphage, a highly abundant
phage in human fecal metagenomes [58]. Both of these observations suggest
that there may be principles underlying the phage community in sewage that
are invariant to geographic location.
When looking into how well known phages are represented in the sewage
samples, we furthermore observed intriguing patters in the ANI distributions.
Two of those seemed to correlate with the Siphoviridae and Myoviridae fami-
lies. Though we do not currently understand the meaning of these patterns,
it would be of interest to investigate whether they could be related to some
property of the phage family, such as a preferential mode of mutation, or to
see if they also hold for phage samples from other environments.
Finally, the third project was centered on identifying gene families in the
accessory genome of the pathogen S. aureus that influence its susceptibility
to phages. For this, 207 strains of MRSA were tested for susceptibility to
12 different phage preparations. As a result, 167 such gene families were
found by building nine successful regression models. Among those were genes
related to prophages and mobile elements, restriction-modification systems
and transcriptional regulators. However, most of the identified gene families
were of unknown function. This illustrates another aspect of the phage suscep-
tibility problem: Though S. aureus is an important pathogen, large parts of
its accessory genome remain poorly characterized. To better understand the
phage-host interaction it will be vital to assign functions to a larger part of
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the host genome.
This project further showed that most gene families were only found to influ-
ence susceptibility to some of the nine phage preparations. In other words,
each of the nine phage preparations had a distinct and specific interaction
with the strain set. This result reinforces the notion that there is an array
of different phage defense mechanisms, at least in S. aureus, and not one
way to gain resistance to the majority of phages. A next step in this line
of questioning could be to experimentally verify whether the identified gene
families are actually causal of phage resistance/susceptibility, for example
via knock-out experiments. There may however be significant challenges to
that because it might actually be a combination of gene families that is caus-
ing the phenotype. Therefore, a large number of experiments may be necessary.
Phage susceptibility is also not purely genetically determined. Environmental
factors can have an influence, for example via an up- or down regulation of
receptor expression. Høyland-Kroghsbo et al describe such a phage defense
mechanism based on quorum sensing in E. coli, where a phage receptor is
down-regulated based on population density [16]. Those effects are not cur-
rently captured in our model, but could be included in future studies.
Understanding the genetic determinants of susceptibility is an important step
forward towards evidence-based selection of the appropriate therapeutic phage
preparation. This ties in with a general movement towards personalization
in medicine. It can furthermore aid in the rational design of phage cocktails
by combining phages for which different sets of resistance-promoting gene
families have been identified. This would indicate that those phages have
different modes of action or at least cannot be evaded with the same strategy.
Using such complementary phages could then delay the development of phage
resistance in the bacterial population.
Looking at the broader picture, the first and third project of this PhD have
dealt with the two principle approaches to phage therapy: Using either stan-
dardized, off-the-shelf cocktails or personalized phage preparations tailored to
the infecting strain. Each of these has merits as well as drawbacks. First-off, a
customized phage preparation is more sure to eliminate specifically the bacte-
rial strain causing the infection and the effect on the commensal microbiome
is minimized. However, this advantage comes with the drawback of needing
to identify the infecting strain prior to treatment. Further, as pointed out
by Pirnay et al in their 2011 commentary, custom-made phage preparations
are not compatible with the current regulatory guidelines as there is not the
time or funding to gain approval for their use through the usual channels, i.e.
clinical trials [9].
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Ready-made cocktails on other hand have been shown by for example the
Eliava Institute to lose efficacy over time and need to be updated by either
adapting the component phages to the current bacterial strains or isolating
new phages [9]. This again creates problems with the current legislation. In
time, guidelines for updating existing cocktails may be set-up, possibly from
a library of approved phages. For now, it is not clear which criteria would
need to be met and which sort of characterization to be provided for a new
phage to be added into an approved product. For more information concerning
this subject see [59] for the publicly available transcripts of the FDA work-
shop on ’Bacteriophage Therapy: Scientific and Regulatory Issues’ in July 2017.
There is no final verdict on this question. However, those two approaches need
not be exclusive of each other. They could also be used in tandem as each
is suited for different purposes. Ready to use cocktails could be applied as a
first line drug and for prophylactic purposes in wound care, as is done in the
Republic of Georgia, where phage preparations are part of the standard medi-
cal care [60]. Custom-made phage preparations could be used for complicated
infections and cases where the standard cocktails have proven ineffective.
In conclusion, after waiting in the wings for many years the time is now right
for phages to takes center stage once more and become an integral part in
combating bacterial infection in Western Medicine. The work presented in this
thesis is a step in the direction of bringing the field of phage research further
towards a future of phage therapy in humans.
Part IV
Appendix
93

95 APPENDIX A. SUPPLEMENTARY MATERIAL FOR PAPER I
A Supplementary Material for Paper I
Table A1. Overview of the trimming parameters and assembler that gave the best result for each phage DNA 
sample. Trimming was based on the output of FASTQC  
Sample Trimming Assembler 
E. coli removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 50 bp 
remove reads with streaks of N longer than 10 
removed 20 nucleotides on the left (3' end) 
removed 10 nucleotides on the right (5' end) 
removed duplicate reads 
Genovo 
Enterococcus removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 50 bp 
remove reads with streaks of N longer than 10 
removed 30 nucleotides on the left (3' end) 
removed 10 nucleotides on the right (5' end) 
removed duplicate reads 
Genovo 
P. aeruginosa 
PAO1 
removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 50 bp 
remove reads with streaks of N longer than 10 
removed 20 nucleotides on the left (3' end) 
removed 50 nucleotides on the right (5' end) 
removed duplicate reads 
Genovo 
P. aeruginosa 
0407431-2 
Untrimmed Velvet 
Proteus Untrimmed Velvet 
Salmonella removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 36 bp 
remove reads with streaks of N longer than 10 
Genovo 
Shigella flexneri removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 50 bp 
remove reads with streaks of N longer than 10 
removed 20 nucleotides on the left (3' end) 
removed 10 nucleotides on the right (5' end) 
removed duplicate reads 
Genovo 
Shigella sonnei removed nucleotides from the right (5' end) according to quality score 
(min 20) 
removed reads according to the mean quality (min 20) 
removed reads shorter than 50 bp 
remove reads with streaks of N longer than 10 
removed 20 nucleotides on the left (3' end) 
removed 10 nucleotides on the right (5' end) 
removed duplicate reads 
Genovo 
 
 
 
Table A2. Overview of the bacterial strains used for small scale susceptibility testing. Observe that all Salmonella 
are of the species Salmonella enterica subsp. enterica but they are identified as different serovars. Reference strains 
are marked with an asterisk. Pathogenic strains are marked with a plus, opportunistic pathogens with a tilde. All 
strains are part of an in-house collection. 
Genus Species/ Serovar Strain Susceptibility 
Salmonella serovar Enteritidis ATCC 13076 *+ Yes 
  serovar Typhimurium ATCC 14028 *+ Yes 
  serovar Saint Paul DVL31 + Yes 
  serovar Newport EQAS1 98-24475-1+ Yes 
  serovar Infantis EQAS1 98-74091-5+ Yes 
  serovar Derby EQAS2 99-65209-5+ Yes 
  serovar Typhimurium DT36 + Yes 
  serovar Enteritidis PT1 + Yes 
  serovar Heidelberg 75-12893-1+ Yes 
  serovar Dublin 1111H11036 + Yes 
Staphylococcus aureus ATCC 29213 *+ No 
  aureus ATCC 25923 *+ Yes 
  epidermidis CCM2354 No 
  pseudointermedius Bjorn 55-4 No 
  hyicus NCTC 10350 No 
  felis Sneleopard Yes 
  lugdunensis E2-1928945 No 
  aureus 76670 CC8 related + Yes 
  aureus Not given+ Yes 
  aureus MSSA A7+ Yes 
Shigella flexneri 1s + Yes 
  sonnei 2s + Yes 
  boydii Not given+ Yes 
  flexneri Not given+ Yes 
  Not given HN-Sh, 2006-001, 2007-5-3 + Yes 
Pseudomonas aeruginosa DMS 1128 / ATCC9027 *~ No 
  aeruginosa Skejby_2~ No 
  aeruginosa 07 52277-1~ Yes 
  aeruginosa PAOI seq ~ Yes 
  aeruginosa 0173267-5~ Yes 
  aeruginosa 0407431-2~ Yes 
  aeruginosa 0107338-1~ Yes 
Escherichia coli ATCC 25922 * Yes 
  coli C  64-12 + No 
  coli C  60-12 + No 
  coli C  23-12 + No 
  coli oedemsyge-45 No 
  coli BW25II3 Yes 
Proteus hauseri DSM 30118/ ATCC 13315 *~ Yes 
  vulgaris DMS 2140/ ATCC 8427 *~ No 
  vulgaris CCUG 36761, ATCC 13315 *~ Yes 
  mirabilis 76499961~ Yes 
  mirabilis E2 1928244~ No 
Enterococcus faecalis 2011-70-7-6 to 2011-70-250-4 ~ No 
  faecium 2011-70-7-8 to 2011-70-252-10~ Yes 
  faecalis 2008-37857~ No 
  faecalis 12 E ~ No 
  faecalis ATCC 29212 *~ Yes 
 
Table A3. Overview of phage clusters identified in the sequencing data of the host-amplified samples. Note that 
many clusters are much smaller in size compared to the corresponding clusters in the full cocktail. Those clusters 
have likely not been amplified by that particular host. Some clusters however, e.g. EntF2 and Pao1_new show a 
great increase in size. This can be explained by the fact that those are infecting clusters (compare Table 4 in the 
text) which are in higher abundance in the host-amplified samples compared to their original numbers in the 
cocktail. Therefore, greater parts of those clusters could be recovered from the amplified samples. 
Phage 
Cluster in 
sample 
Cluster 
size  
in bp 
Corresponding 
cluster in 
INTESTI 
Size ratio to 
corresponding 
cluster 
Amplified on Escherichia coli 
Eco1 9,737 D1 0.07 
Eco2  3,163 D2 0.04 
Eco3 19,979 D3 0.23 
Eco4 1,043 D4 0.02 
Eco5 7,023 D5 0.05 
Eco6 133,873 D6 1.64 
Eco7 17,744 D7 0.30 
Eco9 5,487 D9 0.14 
Eco10 39,747 D10 0.27 
Eco11 4,131 D11 0.07 
Eco12 12,195 D12 0.20 
Eco13 9,105 D13 0.05 
Eco14 185,358 D14 1.39 
Eco15 7,278 D15 0.17 
Eco16 18,144 D16 0.39 
Eco17 78,630 D17 1.91 
Eco18 8,603 D18 0.21 
EcoP 41,317 Proteus phage 0.40 
Amplified on Enterococcus faecalis 
Ent7 58,552 D7 1.01 
Ent11 6,268 D11 0.10 
Ent13 5,282 D13 0.03 
Ent18 41,874 D18 1.02 
EntF2 88,702 F2 7.73 
Amplified on Pseudomonas aeruginosa PAO1_seq 
Pao1_6 9,257 D6 0.11 
Pao1_10 1,477 D10 0.01 
Pao1_12 538 D12 0.01 
Pao1_F1 22,920 F1 1.65 
Pao1_P 3,075 Proteus phage 0.03 
Pao1_new 45,478 - 19.01 
Amplified on Pseudomonas aeruginosa 0407431-2 
PA0407_3 87,742 D3 1.00 
Amplified on Salmonella typhimurium 
Sal3 515 D3 0.01 
Sal6 19,359 D6 0.24 
Sal7 574 D7 0.01 
Sal13 1,047 D13 0.01 
Sal14 717 D14 0.01 
Sal18 46,366 D18 1.13 
SalF2 94,543 F2 8.24 
SalP 670 Proteus phage 0.01 
Amplified on Shigella flexneri 
ShiFl1 2,402 D1 0.02 
ShiFl2 4,799 D2 0.06 
ShiFl3 1,357 D3 0.02 
ShiFl6 21,797 D6 0.27 
ShiFl7 3,946 D7 0.07 
ShiFl9 3,362 D9 0.08 
ShiFl10 1,102 D10 0.01 
ShiFl12 7,707 D12 0.13 
ShiFl13 1,784 D13 0.01 
ShiFl14 177,744 D14 1.34 
ShiFl15 48,286 D15 1.10 
ShiFl16 4,765 D16 0.10 
Amplified on Shigella sonnei 
ShiS2 6,868 D2 0.09 
ShiS6 11,588 D6 0.14 
ShiS14 173,647 D14 1.31 
ShiS15 49,031 D15 1.12 
ShiS16 4,075 D16 0.09 
ShiSP 5715 Proteus phage 0.05 
Amplified on Proteus vulgaris 
Prot17 59,325 D17 1.44 
ProtP 102,963 Proteus phage 0.99 
 
 
 
Figure A1. Examples of two clusters who's depth of coverage had a large standard deviation. The lower the 
contig ID the longer the contig.  
Top: Depth of coverage of cluster D1. Contig 1 which is the longest, has a much lower depth of coverage than the 
short contigs 97 and contig 158. Annotation results showed that many of the genes in contigs 97 and 158 show 
homology to genes annotated as 'terminal repeat-encoded protein (Tre)'. Bottom: Depth of coverage of cluster D6. 
The two short contigs 249 and 258 have much lower depth than the other contigs in that group. We theorize that 
they could represent divergent regions only present in a few of the phages in that cluster. 
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The following supplementary files are available: 
 
1) Supplementary Table S1. 
Table of samples including metadata and the amount of phage DNA in base pairs and percent of 
the full assembly. 
Available at: 
https://docs.google.com/spreadsheets/d/1c6sIiAbWW6UabYiXkH9cR3mv806DctqkKkIXJYklpKA/e
dit#gid=0 
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 The following supplementary files are available: 
 
1) List of inclusion criteria for MRSA strains. 
 
All strains originate from patient samples. Strains were included in the study if they met one or more 
of the following criteria: 
 Having one of the ten most common spa types that occur in Methicillin-sensitive 
Staphylococcus aureus infections  
 Positive for PVL 
 Positive for mecC 
 Being of a rare clonal complex 
 Being of one of the major clonal complexes prevalent in Europe (cc22, cc30, cc45) 
 Being of clonal complex 398 which is typically livestock associated 
Additionally, strains where the sequencing data was of good quality were preferred over strains with 
poor quality sequencing data. 
 
2) Supplementary Table S1. 
List of MRSA strains included in the test set and their properties. 
 
Available at:  
https://docs.google.com/spreadsheets/d/17ciUDM7rJgmCRjMq-
V_xZ23wcd2HrblF206WbtzMst0/edit#gid=0 
 
3) Supplementary Table S2. List of all significant gene families along with the functional annotation 
terms retrieved from comparison to RAST and eggNOG databases. 
A dash ('-') in columns 2-4 indicates that there was no hit found and therefore no annotation term or 
category could be retrieved. Any other entry is the retrieved annotation term, even if it reads 'NA'. In 
columns 6-19 'NA' means the gene family was not found significant in that phage model. 
 
Available at: 
https://docs.google.com/spreadsheets/d/1joM5QoX5FCE3BI5vPiE3ucFwxDcSvRGR8XuJj82Fn6M/edit#
gid=0 
 
4) Supplementary Table S3. Probabilities of observing a given prevalence per functional category 
based on the cumulative density function. In the first column is noted the observed percentage of 
genes in a given category, as depicted in Figure 5. The second column shows the probability of 
observing this percentage or lower given the estimated CDF. Conversely, the third column shows the 
probability of observing an even higher percentage given the eCDF. 
Note that although categories 'Chromatin structure and dynamics' and 'Extracellular structures' 
appear overrepresented in the significant gene set via the cumulative density function, this is 
meaningless since both of categories have been observed zero times in the significant gene set. Those 
two categories are overall extremely rare within our strain set which makes the cumulative density 
function collapse. 
 
Letter category 
percent 
observed 
p(CDF(x)) 
1-
p(CDF(x)) 
p<0.05 direction 
0 No Hit 40.1% 0.99 0.01 yes enriched 
B 
Chromatin structure and 
dynamics 
0.0% 0.98 0.02 yes enriched 
C 
Energy production and 
conversion 
0.6% 0.13 0.87 no 
 
D 
Cell cycle control, cell 
division, chromosome 
partitioning 
1.2% 0.94 0.06 no 
 
E 
Amino acid transport 
and metabolism 
1.8% 0.06 0.94 no 
 
F 
Nucleotide transport and 
metabolism 
0.0% 0.08 0.92 no 
 
G 
Carbohydrate transport 
and metabolism 
1.2% 0.12 0.88 no 
 
H 
Coenzyme transport and 
metabolism 
0.0% 0.06 0.94 no 
 
I 
Lipid transport and 
metabolism 
0.0% 0.12 0.88 no 
 
J 
Translation, ribosomal 
structure and biogenesis 
1.2% 0.17 0.83 no 
 
K Transcription 3.0% 0.24 0.76 no 
 
L 
Replication, 
recombination and repair 
11.4% 0.99 0.01 yes enriched 
M 
Cell 
wall/membrane/envelope 
biogenesis 
5.4% 0.81 0.19 no 
 
N Cell motility 0.0% 0.81 0.19 no 
 
O 
Post-translational 
modification, protein 
turnover, and chaperones 
0.0% 0.04 0.96 yes depleted 
P 
Inorganic ion transport 
and metabolism 
0.6% 0.01 0.99 yes depleted 
Q 
Secondary metabolites 
biosynthesis, transport, 
and catabolism 
0.0% 0.24 0.75 no 
 
S Function unknown 28.7% 0.91 0.09 no 
 
T 
Signal transduction 
mechanisms 
3.0% 0.92 0.08 no 
 
U 
Intracellular trafficking, 
secretion, and vesicular 
transport 
0.0% 0.38 0.62 no 
 
V Defense mechanisms 1.8% 0.33 0.67 no 
 
W Extracellular structures 0.0% 0.97 0.03 yes enriched 
 
 
5) Supplementary Table S4. Detailed phage typing results showing the percentage of resistant, weakly 
susceptible and strongly susceptible bacterial strains per phage preparation. 
 
phage preparation resistant weakly susceptable 
strongly 
susceptable 
1N/80 45.9 22.2 31.9 
676/F 42.5 6.8 50.7 
676/T 30.9 1.0 68.1 
676/Z 55.6 3.9 40.6 
A3/R 77.8 3.4 18.8 
A5/L 51.2 1.4 47.3 
A5/80 40.1 4.8 55.1 
P4/6409 58.9 3.4 37.7 
phi200/6409 45.9 10.1 44.0 
MS-1 58.9 7.2 33.8 
OP_MS-1 54.6 6.8 38.6 
OP_MS-1_TOP 50.7 9.7 39.6 
 
 
6) Supplementary Figure S1. 
Cumulative mean square error of the inner cross validation vs strength of ridge penalty per outer fold 
for the model of phage phi200/6409. It can be seen that the minimum error coincides at similar lambda 
values for the five folds. Other phage models behaved in comparable fashion. 
 
 
 
7) Supplementary Figure S2: P-value distributions of gene enrichment analysis on phage preparations 
a) 1N_80, b) A3_R and c) cocktail MS-1. It can be seen that there is no tail of low p-values as observed 
for the other phages (compare Figure 3) and the distributions resemble more closely that of the 
permuted data for the other phages. 
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